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Ireland
May 2016 saw important developments for those working in 
the illicit drugs area. A new programme for government was 
published and a new Minister for Communities and the National 
Drugs Strategy appointed.
A programme for partnership government was published on 11 May 2016.1 This 
document lays out the direction the new government plans to take across a range 
of policy areas, including those related to drug and alcohol use. 
Subsequently, the Department of Health published its briefing for new ministers  
that describes the work of the department and those responsible for its delivery.2  
Developing the new National Drugs Strategy, providing policy input for the 
legislative changes required to introduce medically supervised injecting centres, 
and pursuing the adoption of the Public Health (Alcohol) Bill are all identified as 
part of the Department of Health’s work.
The newsletter of 
Ireland’s focal point 
to the EMCDDA
Drugs policy in the  
new programme  
for government
Catherine Byrne TD,  
Minister of State for  
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National Drugs Strategy
In brief
In common with many spheres of government 
activity which seek to curtail or manage 
personal freedoms in the interests of the 
perceived common good, drug policy 
confronts tensions between the obligation  
to support the individual citizen’s rights  
and freedoms and the requirement to 
guarantee community safety and maintain 
public support. 
A number of articles in this issue of Drugnet Ireland 
highlight recent reports and papers dealing with the 
impact of current drug policies on human rights. This 
is a global issue and the most severe consequences of 
drug control policies are felt in those societies least 
protective of their citizens’ freedoms and most likely 
to use arbitrary arrest, detention, ill treatment and 
severe sanctions, including the death penalty, in their 
effort to combat drug use. Inadequate or punitive 
treatment regimes further erode rights by denying 
access to effective health care and stigmatising people 
who use drugs. Inevitably, the cost is felt greatest by the 
economically and culturally marginalised and by women 
and ethnic minorities. Of course, these consequences are 
less severe in more democratic societies but high levels 
of incarceration for drug-related offences, poor access 
to effective treatment and restrictions on participation 
in social and economic life all erode the human rights of 
drug users in developed societies. 
The debate on the future of drug control is not confined 
to the specialist policy arena and occurs much more 
frequently in mainstream public discourse as negotiating 
positions are developed for a new global drug strategy 
in 2019. This debate is impacting on current policy and 
human rights are becoming an increasingly important 
lens through which drug policy is analysed. For those 
who emphasise human rights, official recognition that 
drug use is a health rather than a criminal problem is 
a prerequisite for a balanced drug policy. Elsewhere in 
this issue the place of drugs in the new programme for 
government is outlined. 
This commits the government to pursuing a health-led 
rather than a criminal justice approach to drug use and 
continuing with what is generally regarded as a humane 
and progressive drug policy. A consistent commitment to 
a participatory approach to development of responses 
has been key to this policy but the financial crisis and 
security problems have been challenging for those 
working from a community perspective. Human rights 
can provide an ethical underpinning for a policy which 
seeks to protect these communities, maximise their 
contribution and, at the same time, support those with 
drug problems to participate fully in these communities.
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Minister Byrne has been critical of the way in which drug 
services are structured and has expressed concern about the 
duplication of services in some areas.3,4 She has questioned 
the suitability of ‘the drugs task force model’, looking for its 
‘reconfiguration’ so that the needs of users would be better 
met.10 Also she has sought changes to school-based drug and 
alcohol education programmes.4 
At the time of writing it is unclear where the Minister stands 
on the issue of decriminalisation which had been put on 
the agenda by her predecessor Aodhán Ó Ríordáin and the 
findings of the Joint Committee on Justice, Defence and 
Equality.11
Lucy Dillon
 
1  A programme for partnership government (2016)  
http://www.drugsandalcohol.ie/25508/ 
2  Department of Health (2016) Departmental Brief for Minister May 
2016 http://www.drugsandalcohol.ie/25536/ 
3  Byrne C (2015, 26 March) Drug addiction and recovery models. 
Joint Oireachtas Committee on Health and Children. Retrieved 9 
June 2016 https://www.kildarestreet.com/committees/?id=2015-
03-26a.2086&s=Drug+Addiction+and+Recovery+Models 
4 Byrne C (2015, 9 July) National Drugs Strategy. Joint Oireachtas 
Committee on Health and Children. Retrieved 9 June 2016 https://
www.kildarestreet.com/committees/?id=2015-07-09a.3440&s=D
rug+Addiction+and+Recovery+Models#g3455 
5 Byrne C (2015, 23 April) Appointment of Aodhán Ó Ríordáin as 
Minister of State for the National Drugs Strategy. Retrieved 9 
June 2016 http://www.finegael.ie/latest-news/2015/new-drugs-
minister-could-/index.xml 
6 Byrne C (2015, 4 February) Public Health (Alcohol) Bill. Retrieved 
9 June 2016 http://www.finegael.ie/latest-news/2015/new-
legislation-rightly-r/index.xml 
7 Byrne C (2015, 23 April) ‘General Scheme of Public Health 
(Alcohol) Bill 2015’. Joint Committee on Health and Children 
Debate. Retrieved 9 June 2016 https://www.kildarestreet.com/
committees/?id=2015-04-23a.3377&s=I+wholeheartedly+support
+minimum+unit+pricing#g3403
8 Byrne C (2014, 18 June) Cross-Party Oireachtas Group on Alcohol 
Misuse. Retrieved 9 June 2016 http://www.finegael.ie/latest-
news/2014/discussion-of-alcohol-spo/ 
9  Byrne C (2011, 1 December) Alcohol marketing debate. Joint 
Committee on Health and Children. Retrieved 9 June 2016 
http://oireachtasdebates.oireachtas.ie/Debates%20Authoring/
DebatesWebPack.nsf/committeetakes/HEJ2011120100004 
10  Byrne C (2013, 10 July) Estimates for public services 2013. 
Committee on Health and Children: Select Sub-Committee on 
Children and Youth Affairs. Retrieved 9 June 2016 https://www.
kildarestreet.com/committees/?id=2013-07-10a.545 
11  Joint Committee on Justice, Defence and Equality (2015, 5 
November) Report of the committee on a harm reducing and 
rehabilitative approach to possession of small amounts of illegal 
drugs. 31/JDAE/035. http://www.drugsandalcohol.ie/24750/ 
A number of specific commitments have been made in the 
new Programme for Government, including: 
• complete and commence the new National Drugs 
Strategy within 12 months,
• pursue a health-led rather than criminal justice approach 
to drug use,
• legislate for medically supervised injection rooms,
• produce step-down services and facilities for people 
leaving drug rehabilitation,
• enact the Public Health (Alcohol) Bill,
• strengthen the regulation of alcohol advertising to 
children,
• support the expansion of Local Drugs Task Force projects 
and the Garda Youth Diversion programme,
• fund an expansion of youth services to early school 
leavers and other young people,
• reduce drug- and alcohol-related crime through 
a combination of policing, treatment and demand 
reduction activities, and
• properly resource An Garda Síochána to be able to 
reduce the sale and supply of illicit drugs on the streets.
 
New Minister of State for the  
National Drugs Strategy
Following the publication of these documents, on 19 
May Catherine Byrne TD was appointed Minister of State 
for Communities and the National Drugs Strategy. Her 
brief is spread across the Department of Health and the 
Department of Regional Development, Rural Affairs, Arts 
and the Gaeltacht. She is a Fine Gael TD for Dublin South-
Central, a former Lord Mayor of Dublin, and was the party’s 
spokesperson on the National Drugs Strategy from 2007 
to 2010. More recently she has been a member of the 
Oireachtas Cross-Party Group on Alcohol and the Oireachtas 
Committee on Health and Children. She attributes great 
importance to the role of Minister with responsibility for 
the National Drugs Strategy – in 2015 she called for it to be 
upgraded to a Cabinet position.3
Over the years Minister Byrne has made numerous 
contributions to the debate on drug and alcohol issues. With 
respect to the current Government’s priorities, she has been 
a long-standing advocate for the introduction of medically 
supervised injecting centres.4,5 She has given her backing to 
all elements of the Public Health (Alcohol) Bill,6 in particular 
‘wholeheartedly’ supporting the introduction of minimum 
unit pricing for alcohol.7 However, she has argued strongly 
against any alcohol sponsorship of sporting events,8,9 and 
has expressed the view that the Bill does not go far enough 
in relation to this issue. For example, in February 2015 she 
urged the Minister for Health to ‘re-examine how we can 
curtail alcohol sponsorship of sporting events because we 
need to send out a strong message that alcohol has no place 
in our sporting events’.8
new Programme for 
government and new 
drugs Minister  continued
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16 Prevention 
This area of the strategy deals with both illicit drugs and 
alcohol. It continued to be the case that since the start 
of the strategy, most progress was made in setting up 
education programmes and drug policies in schools, 
developing youth interventions and facilities in out-of-school 
settings, and developing online prevention and help services. 
Work was on-going in progressing programmes targeting 
families experiencing difficulties owing to drug/alcohol use 
and the children of drug users. Work was also under way on 
selective prevention measures to reduce under-age and 
binge drinking. 
treatment and rehabilitation 
Activity under the treatment and rehabilitation pillar is 
mainly illustrated by using examples of activities from CHOs. 
The overall message for 2015 was the same as in 2014 – the 
development and improvement of the range, integration and 
availability of treatment and rehabilitation services were 
reported to be on-going, as was improvement in access 
to these services. With regard to a drugs intervention 
programme (incorporating a treatment referral option) for 
young people who come to the attention of the Gardaí as 
a result of their drug use, Gardaí now have an information 
leaflet to give to young people. 
No further action was reported since the last report in 
relation to the following actions:  
• While work was reported to be well under way with 
regard to training programmes for all involved in the 
provision of substance misuse treatment services, 
treatment guidelines for treating blood-borne viruses 
had yet to be published. 
• In response to the issue of drug-related deaths, the 
findings of the naloxone demonstration project were  
still awaited. 
• No progress was reported in relation to the development 
of a National Overdose Prevention Strategy nor to 
the review of the regulatory framework in relation to 
prescription drugs.
• A statutory regulatory framework for the provision of 
counselling within substance misuse services continued 
to be delayed because counselling was not one of the 12 
health and social care professions designated under the 
Health and Social Care Professionals Act 2005.
Research and information
Many activities under this pillar were on-going. The five key 
epidemiological indicators relating to drug use (prevalence 
in general population, prevalence and patterns of use of 
specific drugs, drug treatment demand, drug-related deaths 
and infectious diseases) and the associated data collection 
systems were all under continuous development. The HRB 
National Drugs Library continued to promote the use of 
evidence in drugs work and provide resources to those 
working in the area. In line with the EU Early Warning System, 
a communication protocol for notification of drug use 
emergencies was being further developed. 
The 2015 research work programme of the National Advisory 
Committee on Drugs and Alcohol was the same as for 2014. 
Progress was hindered owing to the lack of a researcher and 
a reduced budget. 
POLICY AND LEGISLATION 
National Drugs 
Strategy: progress  
in 2015
The Department of Health has published its annual report  
for 2015 on progress in implementing the actions included 
in the National Drugs Strategy.1 The report is a descriptive 
account of activities over the period – in some cases 
they are reported at a national level, while in others they 
are reported at the level of the Community Healthcare 
Organisations (CHOs).2 
Where there has been no change, the report tends to repeat 
the 2014 content. No reference is made in the report to the 
key performance indicators identified in the NDS and neither 
is there any overall assessment of the level of progress made 
in achieving outcomes. The overall messages under each 
pillar remain the same as in the 2014 report.3 
This article focuses on some of the changes reported to  
have happened under each of the five pillars over the 
12-month period.
Supply reduction
Overall progress in delivering on the supply reduction actions 
continued to be made in relation to local supply reduction 
initiatives, and compliance with EU-level obligations and 
operations. In 2015 progress was made on policy and 
legislative initiatives, including the Road Traffic Bill 2016, the 
Public Health (Alcohol) Bill 2015, and the proposed bill to 
amend the Misuse of Drugs Act to restore the government’s 
power to declare substances to be controlled. Furthermore, 
some progress was made on activities that had been 
affected by the difficult economic situation: 
• Forensic Science Ireland (FSI) received €1 million 
additional funding in the 2016 estimates for additional 
staff members. 
• Funding was also allocated for a new forensic science 
laboratory. Construction is due to start in 2019. 
• The DNA database was launched late in 2015 and is being 
used by the Gardaí and FSI. 
• Some steps were taken to meet the need for an 
integrated system to track the progression of offenders 
with drug-related offences through the criminal justice 
system. A Chief Information Officer was appointed with 
responsibility for developing the concept of a ‘justice and 
equality information hub’; approval was given for three 
‘Pathfinder’ projects to prove the concept. 
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However, there were some specific developments: 
• The development of indicators for harm reduction, public 
expenditure and drugs and crime, was under way. In 
2015, for the first time, data on drug treatment in prisons 
were included in the report on prisons provided to the 
EMCDDA. 
• The HSE was finalising a plan for the establishment and 
rollout of the Individual Health Identifier (IHI).
Co-ordination 
There was little change in relation to this pillar, with many of 
the proposed structures already in place. Some progress was 
made in developing engagement with specifically identified 
at-risk groups, including Travellers, new communities, LGBTs, 
the homeless and sex workers. 
A subgroup of the National Coordinating Committee for Drug 
and Alcohol Task Forces reviewed and updated the 2009 
NDS Traveller Framework Document, and was identifying lead 
agencies to implement the recommendations in the document. 
Lucy Dillon
1  Department of Health (2016) National Drugs Strategy 2009-
2016: progress report to end 2015. http://www.drugsandalcohol.
ie/25365/
2  Delivered through the HSE and its funded agencies, the nine 
Community Healthcare Organisations provide the broad range 
of services that are delivered outside of the acute hospital 
system, i.e. primary care, social care, mental health and health 
and wellbeing services. https://www.hse.ie/eng/services/
publications/corporate/CHO_FAQ.pdf 
3  Pike B (2015) National Drugs Strategy [NDS] 2009–2016: 
progress in 2014 Drugnet Ireland (55): 12– 13. http://www.
drugsandalcohol.ie/view/journal_volume/Drugnet_Ireland/
Issue_55,_Autumn_2015.html
ndS progress in 2015  continued
What are  
human rights?
According to the Irish Human Rights and Equality Commission 
(IHREC), ‘human rights are the basic rights and freedoms 
that belong to everyone. International law, including treaties, 
contain the provisions which give human rights legal effect.’1 
In the decades since World War Two, human rights standards 
have been adopted at United Nations, Council of Europe 
and the European Union level. Ireland has committed to 
upholding many of these standards. 
United Nations (UN)
Adopted by the UN General Assembly 
on 10 December 1948, the Universal 
Declaration of Human Rights (UDHR) 
spelt out for the first time in human 
history basic civil, political, economic, 
social and cultural rights that all 
human beings should enjoy. It set ‘a common  
standard of achievement for all peoples and nations’. 
There are nine core international human rights instruments. 
Each of these instruments has established a committee of 
experts to monitor implementation of the treaty provisions 
by its States parties.
1. International Covenant on Civil and Political Rights (1966)
2.   International Covenant on Economic, Social and Cultural 
Rights (1966)
3.   Convention on the Elimination of All Forms of Racial 
Discrimination (CERD)(1965)
4.   Convention on the Elimination of All Forms of 
Discrimination against Women (CEDAW) (1979)
5.   Convention against Torture and Other Cruel, Inhuman or 
Degrading Treatment or Punishment (CAT) (1984)
6.  Convention on the Rights of the Child (1989)2
7.   Convention on the Protection of the Rights of All Migrant 
Workers and Members of Their Families (1990)
8.   Convention on the Rights of Persons with Disabilities 
(CPRD)(2006)
9.   Convention for the Protection of All Persons from 
Enforced Disappearance (CPPED)(2006)
Ireland has ratified the first six of these Conventions.
Additional information on the UN treaties can be found at  
http://www.ohchr.org/EN/ProfessionalInterest/Pages/
CoreInstruments.aspx
Europe
Protection of human rights in Europe (a ‘regional system’) 
is provided by two institutions with separate sets of laws 
and courts – (1) the Council of Europe system comprising 
the European Convention on Human Rights, the Revised 
European Social Charter and the European Court of Human 
Rights, and (2) the European Union system comprising the 
Charter of Fundamental Rights, the EU Directives on Equality 
and the Court of Justice of the European Union.
Council of Europe system 
When it came to giving binding legal 
force to the rights in the UDHR, the 
Council of Europe adopted two 
separate treaties – the European 
Convention of Human Rights, which 
guarantees civil and political rights, 
adopted in 1950, and the European 
Social Charter, which guarantees social and  
economic rights, e.g. everyday human rights related  
to employment, housing, health, education, social 
protection and welfare, adopted in 1961. The European Court 
of Human Rights rules on individual or State applications 
alleging violations of the civil and political rights set out in 
the European Convention on Human Rights.
Additional information can be found at
European Convention on Human Rights http://www.echr.
coe.int/Documents/Convention_ENG.pdf 
European Social Charter http://www.coe.int/en/web/
conventions/full-list/-/conventions/treaty/163 
European Court of Human Rights http://www.echr.coe.int/
Pages/home.aspx?p=home&c=
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16 What are human rights?  continued
European Union (EU) system 
The EU’s Charter of Fundamental Rights 
brings together in a single document 
the fundamental rights protected in 
the EU. The Charter contains rights 
and freedoms under six titles: Dignity, 
Freedoms, Equality, Solidarity, Citizens’ 
Rights, and Justice. 
Proclaimed in 2000, the Charter became legally binding on 
the EU with the entry into force of the Treaty of Lisbon in 
December 2009. The Court of Justice of the European Union 
interprets EU law to make sure it is applied in the same 
way in all EU countries, and settles legal disputes between 
national governments and EU institutions. 
Additional information can be found at
Charter of Fundamental Rights http://www.europarl.europa.
eu/charter/pdf/text_en.pdf
Court of Justice of the European Union http://europa.eu/
about-eu/institutions-bodies/court-justice/index_en.htm
Ireland
Bunreacht na hÉireann (the Irish Constitution) 
was signed into law in 1937. Articles 38–44 set 
out fundamental rights. The Irish courts have 
interpreted the Constitution as including certain 
other human rights, i.e. ‘unenumerated rights’, 
which are not explicitly set out in the Constitution 
but are recognised by the courts. 
The European Convention on Human Rights Act 2003  
gives effect to the standards set out in the European 
Convention on Human Rights in Irish law. This allows  
these rights to be considered before the Irish courts.  
The Constitution has primacy over the ECHR Act (in  
cases where there is any uncertainty) and, if the two 
conflict, the Constitution prevails.
Additional information can be found at
Bunreacht na hÉireann http://www.taoiseach.gov.ie/eng/
Historical_Information/The_Constitution/ 
European Convention on Human Rights Act 2003 http://
www.ihrec.ie/legal/europeanconvent.html 
this account has been compiled with the assistance  
of the Irish Human Rights and Equality Commission,  
www.ihrec.ie 
1  Irish Human Rights and Equality Commission (2015) Human 
rights explained: guide to human rights law. Dublin: IHREC, p. 
6. http://www.ihrec.ie/download/pdf/ihrec_human_rights_
explained.pdf 
2  Article 33 of the Convention on the Rights of the Child reads: 
‘States Parties shall take all appropriate measures, including 
legislative, administrative, social and educational measures, 
to protect children from the illicit use of narcotic drugs and 
psychotropic substances as defined in the relevant international 
treaties, and to prevent the use of children in the illicit 
production and trafficking of such substances.’
Drug users’  
human rights 
Just what are the rights of drug users and how can 
legislators, policy makers, law enforcers and service providers 
ensure their rights are taken into consideration? In 2015 the 
Irish Council for Civil Liberties (ICCL) produced its first paper 
considering the drugs phenomenon from a human rights 
perspective, and in particular human rights as defined in the 
European Convention on Human Rights (ECHR).1
Right to life (Art 2 ECHR)
With an average 600 drug-related deaths every year,2 Ireland 
has almost four times the overall European Union (EU) 
average. ICCL identifies six harm reduction measures to help 
reduce this number, some of which have already been, or are 
in the process of being, introduced, and some of which are 
under discussion. 
Prohibition of torture and inhuman or 
degrading treatment or punishment  
(Art 3 ECHR)
According to ICCL, persons with drug problems suffer 
considerably and their health is eroded by street drugs and 
by drug-taking practices, and there is also transmission 
and high prevalence of blood-borne viruses among the 
drug-using population. Compounded by the stigmatisation 
associated with substance misuse, these and a range of 
other conditions can be perceived by the persons suffering 
them as inhuman or degrading. Policies focusing on drug 
use as a health problem rather than a criminal problem 
might strike a better balance in addressing these human 
rights concerns. 
Drug use may be the result of lack of access to palliative 
treatment or failure by service providers to respond to 
the real or perceived somatic or mental health needs or 
conditions of the user, for example undisclosed traumatic 
experiences such as abuse suffered during childhood, that 
render a person more vulnerable to problematic substance 
use. ICCL invites policy makers to examine the degree to 
which suffering might be reduced or prevented, and non-
medical use of prescription drugs or use of illegal drugs 
reduced, if doctors were to have greater prescription 
freedom, subject only to professional standards, without 
a criminal policy inspired gatekeeping role and associated 
sanctions for doctors perceived as over-prescribing 
psychoactive substances. 
Prohibition of forced labour/slavery  
(Art 4 ECHR)
Drug policies that stigmatise, marginalise and exclude users 
often push them into the hands of persons who exploit 
them sexually or otherwise in situations that are tantamount 
to forced labour, sometimes modern slavery. ICCL asks 
whether different policies would eliminate these situations, 
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Prohibition of discrimination (Art 14 ECHR)
ICCL notes that drug laws affect far more people in 
disadvantaged communities than in other communities, 
although drug use is roughly the same across all communities. 
It also notes that some people argue that subordinating the 
treatment of substance use disorders to criminal policy or 
related moral considerations, as compared to other self-
inflicted conditions that remain a purely medical matter, 
is also discriminatory. Examples of self-inflicted medical 
conditions that don’t attract a criminal charge include 
tobacco-related cancer, alcohol-related diseases, diet-
related hypertension, certain cases of diabetes, extreme 
sport-related injury or even suicide attempts. 
ICCL suggests that these biases can affect access to and 
the modalities of palliative, substitution or maintenance 
treatment for substance use disorders, and invites policy 
makers to consider whether current drug policies that hinge 
on criminal law and repression (a) have an unnecessary, 
undesirable or discriminatory impact on the delivery 
of health care for persons suffering from substance 
use disorders, and (b) place the persons concerned in 
significantly less favourable conditions for access to and 
quality of treatment than people who suffer from other self-
inflicted medical conditions. 
Brigid Pike
1  Irish Council for Civil Liberties (2015, 6 August) Submission to 
the Houses of the Oireachtas Joint Committee on Justice, 
Defence and Equality on the review of Ireland’s approach to the 
possession of limited quantities of certain drugs. Retrieved 28 
April 2016 http://www.drugsandalcohol.ie/25444/
2  Health Research Board (2015) Drug-related deaths and deaths 
among drug users in Ireland: 2013 figures from the National 
Drug-Related Deaths Index. Dublin: Health Research Board. 
http://www.drugsandalcohol.ie/24676/ 
and if so, does this raise questions from a human rights 
perspective. Although not under the potential scope of 
Article 4, ICCL notes that working conditions and work-place 
environments may be conducive to drug use. This may occur 
because of work-related stress, unreasonable performance 
objectives or demands, or an excessively competitive 
atmosphere. Performance enhancement drugs can also lead 
to problematic use.
Right to liberty and personal freedom  
(Art 5 ECHR)
Using UN estimates, ICCL points out that there may be 
around 30 million occasional drug users in the EU, and some 
5 million problematic drug users. However, the EMCDDA 
reported only 1.25 million drug offences in the EU in 2014. Of 
these, 781,000 were for cannabis use and a further 223,000 
involved use of other drugs; cannabis supply amounted 
to 116,000 recorded offences, with supply of other drugs 
accounting for 86,000 and other offences 42,000. Based 
on these figures, ICCL suggests that the application of 
criminal law to drugs is uneven and therefore risks being 
discriminatory. If use were punished systematically, ICCL 
asserts it would mean criminalising within the EU the 
equivalent of seven times the population of the Republic of 
Ireland, or more than once its population if only problematic 
users were targeted. 
The ICCL asks whether drug-related criminal law fails on 
three counts:  
• its vocation of general non-discriminatory application, 
while drug trafficking continues to be rampant despite 
considerable law enforcement efforts; 
• its purpose of preserving public health given the scale of 
the drug problem and the reported collateral damage of 
drug policy; and 
• its purpose of protecting children. 
Right to private life, freedom of thought, 
expression, association (cf. Arts 8, 9, 10, 11 …)
Referring to the right to private life, ICCL suggests this right 
arguably extends to enjoying an experience of one’s choice, 
including those that alter one’s mental perceptions or state 
of consciousness, especially if it does not transcend to the 
public or endanger others. ICCL goes on to point out that the 
interdiction of such activities (in terms of their mind-altering 
power) would be contrary to Article 8, unless provided for 
in law ‘in the interests of national security, public safety or 
the economic wellbeing of the country, for the prevention of 
disorder or crime, for the protection of health or morals, or 
for the protection of the rights and freedoms of others’. The 
objective pursued would have to be demonstrably necessary 
in a democratic society and the interference proportionate. 
ICCL goes on to suggest that policy makers might wish 
to take such matters into account when considering 
decriminalisation and the home-growing of cannabis.
drug users’ human rights continued
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16 Human rights 
and drug policy 
– international 
perspectives
The work of four international bodies with a particular 
interest in investigating just what a human-rights based 
approach to drug policy might look like is outlined below.
International Centre on Human Rights and 
Drug Policy (HRDP)
The International Centre on Human Rights and Drug 
Policy (HRDP) is dedicated to developing and promoting 
innovative and high-quality legal and human rights research 
and teaching on issues related to drug laws, policy and 
enforcement. It pursues its mandate by publishing original, 
peer-reviewed research on drug issues as they relate to 
international human rights law, international humanitarian 
law, international criminal law and public international law.
In a six-page joint submission to the 2016 UNGASS on drugs, 
HRDP and Amnesty International took the following view:1
The UNGASS on drugs must be viewed as the 
beginning of a wider reflective process underpinned 
by a rigorous and inclusive assessment of the 
global state of drug control in the negotiations of a 
new Political Declaration and Plan of Action to be 
adopted in 2019. The lead up to 2019 is a critical 
moment to ensure that political commitments to 
drug control have clear, unambiguous articulations 
of international human rights law and standards.
International Network of People Who Use 
Drugs (INPUD)
The International Network of People who Use Drugs (INPUD) 
is a global peer-based organisation that seeks to promote 
the health and defend the rights of people who use drugs. In 
October 2015 it published a 42-page ‘consensus statement’ 
on human rights, health, and the law in relation to people who 
use drugs.2 The statement lists ten ‘established and recognised 
human rights’ to which people who use drugs are entitled:
1. human rights, which must be protected by the  
 rule of law;
2. the right to non-discrimination;
3. the right to life and security of person; 
4.  the right not to be subjected to torture or to cruel, 
inhuman, or degrading treatment;
5. the right to the highest attainable standard of health;
6.  the right to work, to free choice of employment, to just 
and favourable conditions of work, and to protection 
against unemployment;
7.  the right not to be subjected to arbitrary arrest or 
detention; 
8. the right to bodily integrity; 
9.  the right to found a family entitled to protection by the 
law, entitled to privacy, and entitled to be free from 
arbitrary interference; and
10. the right to assemble, associate, and form organisations.
Johns Hopkins–Lancet Commission on  
Drug Policy and Health
Ahead of UNGASS 2016 on drugs, the Johns Hopkins–Lancet 
Commission, comprising 22 experts from a wide range of 
disciplines and professions in low-, middle- and high-income 
countries, examined the emerging scientific evidence on 
public health issues arising from drug-control policy in 
order to inform and encourage a central focus on public 
health evidence and outcomes in drug policy debates. 
The Commission’s work was framed by the UN-endorsed 
Sustainable Development Goals (SDGs) for 2030, which 
aspire to human-rights-centred approaches to ensuring the 
health and wellbeing of all people. In their 50-page report, 
the Commission made 11 recommendations regarding future 
drug policy, including the following: 
• Decriminalise minor, non-violent drug offences – use, 
possession, and petty sale – and strengthen health and 
social-sector alternatives to criminal sanctions.
• Ensure easy access to harm-reduction services, e.g. 
opioid substitution treatment, nsp, supervised injection 
sites and access to naloxone, for all who need them, and 
recognise the effectiveness and cost-effectiveness of 
scaling up and sustaining these services. 
• Prioritise people who use drugs in treatment for HIV, 
HCV infection, and tuberculosis, and ensure that services 
are adequate to enable access for all who need care. 
• Reduce the negative impact of drug policy and law 
on women and their families, especially by minimising 
custodial sentences for women who commit nonviolent 
offences and developing appropriate health and social 
support, including gender-appropriate treatment of drug 
dependence, for those who need it.
• Health, development and human rights indicators should 
be included in metrics to judge success of drug policy, 
e.g. access to treatment, frequency of overdose deaths, 
and access to social welfare programmes for people who 
use drugs. All drug policies should also be monitored 
and assessed as to their impact on racial and ethnic 
minorities, women, children and young people, and 
people living in poverty.
• Move gradually toward regulated drug markets and apply 
the scientific method to their assessment.
Pompidou Group 
Part of the Council of Europe, the Pompidou Group 
comprises 38 states, including Ireland. Its core mission 
is to contribute to the development of multidisciplinary, 
innovative, effective and evidence-based drug policies in its 
member states. ‘Bringing human rights to the forefront of 
drug policy’ is its top priority for 2015–2018. 
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The aims of the Pompidou Group’s current work  
programme include:
• increasing awareness of human rights obligations and 
reduction in human rights violations occurring in the 
pursuit of drug policy goals; 
• contributing to reducing stigmatisation and 
discrimination; 
• promoting the right of access to healthcare for drug 
dependent people in detention; 
• highlighting and recognising the pivotal role of the 
Pompidou Group, as a part of the Council of Europe, in 
promoting human rights as a fundamental drug policy 
principle; and
• promoting the mainstreaming of gender aspects in all 
areas of drug policy.  
Brigid Pike
1  International Centre on Human Rights Centre and Amnesty 
International (2016, 12 April) Joint submission: The promotion 
and protection of human rights and international drug 
control. Retrieved 28 April 2016 http://www.hr-dp.org/
files/2016/04/12/AI_HRDP_UNGASS_Submission_FINAL1.pdf 
2  INPUD (2015) Consensus statement on drug use under 
prohibition: human rights, health and the law. London: INPUD. 
Retrieved 28 April 2016 http://www.inpud.net/en/news/inpud-
consensus-statement-drug-use-under-prohibition-human-
rights-health-and-law 
3  Johns Hopkins–Lancet Commission on Drug Policy and Health 
(2016) Public health and international drug policy Lancet Vol. 
387: 1427–1480. Published Online, 24 March 2016, http://dx.doi.
org/10.1016/S0140-6736(16)00619-X 
4  Pompidou Group (2014) Pompidou Group work programme 
2015–2018: ‘Drug policy and human rights: new trends in 
a globalised context’. P-PG/MinConf (2014) 4. Retrieved 
28 April 2016 http://www.coe.int/T/DG3/Pompidou/
Source/Documents/P-PG_MinConf%20(2014)%204%20
WorkProgramme%202015-18_ENGLISH.pdf 
Human rights – international 
perspectives continued
Human rights, 
equality and the 
National Drugs 
Strategy
In 2014 Ireland became the first EU member state to 
introduce legislation that combines equality and human 
rights as a ‘public sector duty’. This public sector duty 
requires public bodies to take proactive steps to promote 
equality, protect human rights and fight discrimination in 
relation to their functions and powers. Section 42 of the Irish 
Human Rights and Equality Commission Act 2014 states:1
A public body shall, in the performance of its functions have 
regard to the need to: 
a) eliminate discrimination,
b)  promote equality of opportunity and treatment of its 
staff and the persons to whom it provides services, and
c)  protect, promote and fulfil the human rights of its 
members, staff and the persons to whom it provides 
services.
The Act requires public bodies both to set out in their 
strategic plans an assessment of the human rights and 
equality issues it believes to be relevant to its functions and 
purpose, and to have policies, plans and actions in place to 
address those issues, or to include proposals on how such 
policies and plans will be put in place. Annual reports need 
to report on developments and achievements in regard to 
these issues. 
The Irish Human Rights and Equality Commission (IHREC), 
established under the 2014 Act, published its first strategy 
in January 2016, covering the years 2016–2018. One of the 
goals in the strategy is the ‘proactive implementation of 
our legal powers, in particular positive public duty’.2 Among 
the outcomes the Commission will be measuring in relation 
to this goal are whether there is an increase in awareness 
of human rights and equality issues, and in positive action 
among ‘duty bearers’, i.e. public bodies.
It is within this legislative context that Niall Crowley, the 
former Chief Executive Officer of the now defunct Equality 
Authority in Ireland (1999–2009), gave a presentation at 
CityWide’s 20th anniversary conference in November 2015.3 
He explored the opportunities that this statutory public 
sector duty offers the National Drugs Strategy. He discussed 
how to develop an equality and human rights statement for 
the strategy that will ensure equality and human rights are 
built into the planning, implementation and evaluation of 
the strategy. He also noted that this public sector duty will 
ensure the full integration of ‘communities of interest’ such 
as LGBT, travellers, New Communities and other minority 
groups, into the development of the strategy.4
 
Lucy Dillon 
1  Irish Human Rights and Equality Commission Act 2014 http://
www.irishstatutebook.ie/eli/2014/act/25/enacted/en/html 
2  Irish Human Rights and Equality Commission (2016) Strategy 
statement 2016–2018. Dublin: IHREC, p. 9. Retrieved 30 June 
2016 http://www.ihrec.ie/download/pdf/strategystatement.pdf 
3  Niall Crowley’s presentation is available at http://www.citywide.
ie/citywide-20th-anniversary/workshops.html 
4  For an account of human rights and drug policy in Ireland prior 
to the finalisation of the current National Drugs Strategy, see B 
Pike (2008) Human rights and illicit drugs policy. Drugnet Ireland 
(27): 11–12. http://www.drugsandalcohol.ie/12108/
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16 After UNGASS 2016
UNGASS 2016 has been and gone. Held on 19–21 April in New 
York, it comprised not only the general assembly sessions but 
also over 40 side events, which were organised by individual 
member states, UN agencies and international NGOs.1 
Two policy statements to emerge from the UNGASS 
process that are relevant to Ireland’s national drugs policy 
are described below. The language used and the points 
emphasised in the two papers differ, particularly in relation 
to demand reduction, supply reduction and human rights 
issues, reflecting the challenges of reaching a consensus 
among 28 European countries as opposed to some 200 
countries from around the globe.2
EU common position
Ahead of UNGASS 2016, the European Union (EU) adopted 
a common position paper, which formed the basis for 
EU member states’ contributions.2 Grounded on two 
general principles – the need for an integrated, balanced 
and evidence-based approach and a sound public health 
approach – the nine-page position paper is broken into ten 
sections, listed below, which contain a total of 36 policy 
statements, some of which are noted here.
• International legal framework – there is ‘sufficient scope 
and flexibility within the provisions of the UN Conventions 
to accommodate a wide range of approaches to drug 
policy’;
• Human rights – states parties are invited ‘to develop 
and implement, when appropriate, alternatives to 
incarceration and coercive sanctions applicable to 
persons having committed minor, non-violent drug-
related offences’;
• Role of civil society in formulating, implementing, 
monitoring and evaluating drug policies, ‘especially in the 
field of drug demand reduction’ is affirmed;
• Demand reduction and related measures, including 
prevention and treatment – ‘dependent drug users 
should be first and foremost considered as people 
in need of attention, care and treatment in order to 
improve their health and condition and enhance social 
integration, tackling marginalization and stigmatization’ 
and, in this context, states parties ‘should make sure 
that access to risk and harm reduction measures is 
guaranteed, as such measures have proved effective in 
reducing the number of direct and indirect drug-related 
deaths and notably blood-borne infectious diseases 
associated with drug use’;
• Access and availability of drug demand reduction 
measures – states parties are urged to ‘guarantee broad 
availability, coverage and access’ to drug dependence 
treatment for all members of society’;
• Availability of controlled substances for medical and 
social purposes – ‘as regards psychoactive substances 
with proven legitimate medical or scientific use, a 
thorough and careful assessment is crucial before 
a decision is taken, with a view to avoiding undue 
restrictions on legitimate use of such substances’;
• Supply reduction and related measures – covers drug 
trafficking, international cooperation, with particular 
attention to the spreading and diversification of 
precursor chemicals;
• Alternative development – to establish viable economic 
alternatives to prohibited cultivation of crops in source 
countries;
• Drugs policy and children, youth and women – reference 
is made to article 33 of the Convention on the Rights 
of the Child, asserting the need ‘to protect children 
from the illicit use of narcotic drugs and psychotropic 
substances’, and differences in the ways men and 
women are affected by drugs and drug policies are 
acknowledged;
• New challenges, threats and realities in preventing 
and addressing the world drug problem including 
new psychoactive substances and the role of new 
communication technologies.
UNGASS outcome statement
Agreed by member states at the 59th meeting of the 
UN Commission on Narcotic Drugs (CND) in Vienna in 
March 2016, this outcome document, entitled ‘Our joint 
commitment to effectively addressing and countering the 
world drug problem’, was adopted at UNGASS 2016.3 Having 
reaffirmed member states’ commitment to the three UN 
drug conventions and member states’ determination ‘to 
tackle the world drug problem and to actively promote a 
society free of drug abuse in order to help ensure that all 
people can live in health, dignity and peace, with security 
and prosperity and to address public health, safety and 
social problems resulting from drug abuse’, the 24-page 
outcome statement sets out a series of operational 
recommendations under seven headings. 
Demand reduction and related measures, including 
prevention and treatment  
Under treatment, the document eschews use of the term 
‘harm reduction’ but invites national authorities to consider 
‘effective measures aimed at minimizing the adverse public 
health and social consequences of drug abuse, including 
appropriate medication-assisted therapy programmes, 
injecting equipment programmes, as well as antiretroviral 
therapy and other relevant interventions that prevent the 
transmission of HIV, viral hepatitis and other blood-borne 
diseases associated with drug use’. 
Availability of and access to controlled substances 
exclusively for medical and scientific purposes  
Focuses on improving processes for ensuring availability  
and access.
Supply reduction including law enforcement, drug-related 
crime, money laundering and judicial cooperation  
As well as strengthening efforts to tackle international drug 
trafficking and its links to other forms of organised crime, the 
outcome statement calls on member states to strengthen 
multi-disciplinary measures to ‘promote comprehensive 
supply reduction efforts that include preventive measures 
addressing, inter alia, the criminal justice and socio-
economic related factors that may facilitate, drive, enable 
and perpetuate organized crime and drug-related crime’.  
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Cross-cutting issues: human rights, youth, children,  
women and communities  
Along with nine recommendations regarding youth, children 
and women, the outcome statement discusses the need for 
proportionate and effective policies and responses in the 
criminal justice sector, in compliance with the provisions of 
the three UN drug conventions. Recommendations include 
encouraging the development, adoption and implementation 
of ‘alternative or additional measures with regard to 
conviction or punishment of an appropriate nature’ and 
also promoting ‘proportionate national sentencing policies, 
practices and guidelines for drug-related offences whereby 
the severity of penalties is proportionate to the gravity 
of offences and whereby both mitigating and aggravating 
factors are taken into account’. 
Cross-cutting issues in countering the world drug problem
This section contains 25 recommendations relating to new 
psychoactive substances, amphetamine-type stimulants, 
precursors, and the non-medical use of prescription drugs, 
as well as enhancing capacity to respond the evolving reality 
and emerging and persistent challenges and threats.
Strengthening international cooperation  
This will continue to be based on the principle of common 
and shared responsibility, strengthening assistance and 
enhancing cooperation between member states. 
Alternative development  
This section sets out the measures by which UN member 
states will address drug-related socio-economic issues 
related to the illicit cultivation of narcotic plants and the 
illicit manufacture and production and trafficking of drugs 
around the world.
Two reports – one by Ireland’s Department of Health and one 
by an international non-governmental organisation – assess 
what UNGASS 2016 achieved.
Ireland’s Department of Health
In its briefing to the incoming Minister for Health in May 2016, 
the Department of Health wrote:
The UN General Assembly held a Special Session 
(UNGASS) on drugs from 19th to 21st April 2016 in 
New York. This Special Session was an important 
milestone in achieving the goals in the policy 
document of 2009 ‘Policy Declaration and Plan 
of Action on International Cooperation towards 
an Integrated and Balanced Strategy to Counter 
the World Drug Problem’ which defined action to 
be taken by Member States as well as goals to be 
achieved by 2019. An Outcomes Document, adopted 
by acclaim at the first plenary session, contained a 
series of operational recommendations to counter 
the world drug problem. It showed progress in 
agreeing language on proportional sentencing, the 
importance of evidence-based policies, gender 
mainstreaming, greater consideration of human 
rights aspects, new psychoactive substances/NPS, 
and in taking account of WHO resolutions.4
International Drug Policy Consortium (IDPC)
IDPC is global network of 143 NGOs that focus on issues 
related to drug production, trafficking and use, promoting 
objective and open debate on the effectiveness, direction 
and content of drug policies at the national and international 
level, and supporting evidence-based policies that are 
effective at reducing drug-related harm. IDPC commented 
regarding UNGASS 2016:
Although the Outcome Document does include 
some good language on some points (such as access 
to essential medicines, development, overdose 
prevention and alternatives to incarceration), it 
could have been a very different document if the 
more progressive inputs had not been overlooked. 
IDPC has compiled a document containing a selection of the 
‘more strong, progressive and evidence-based language’, 
which had been on the table during the negotiations.5 
Brigid Pike
1  Information retrieved 13 May 2016 https://www.unodc.org/
ungass2016/ 
2  European Union (2016) Common position on UNGASS 2016. 
Retrieved 13 May 2016 http://www.unodc.org/documents/
ungass2016//Contributions/IO/EU_COMMON_POSITION_ON_
UNGASS.pdf 
3  Draft resolution submitted by the President of the General 
Assembly: Our joint commitment to effectively addressing 
and countering the world drug problem. 14 April 2016. E/
CN.7/2016/L.12/Rev.1. Retrieved 13 May 2016 https://
documents-dds-ny.un.org/doc/UNDOC/LTD/V16/017/77/PDF/
V1601777.pdf?OpenElement 
4  Department of Health (2016) Departmental Brief for Minister 
May 2016. http://www.drugsandalcohol.ie/25536/
5  Document retrieved 10 June 2016 https://
dl.dropboxusercontent.com/u/64663568/Press%20releases/
UNGASS-shadow-declaration_FINAL.pdf 
After UNGASS 2016 continued
12
dr
ug
ne
t I
R
EL
AN
D
   
   
Is
su
e 
58
 |  
Su
m
m
er
 2
0
16
While data on some indicators, such as treatment demand, are 
supplied annually, the year of the most recent prevalence data 
can vary. 
Cannabis
The EMCDDA estimates that around 16.6 million (13.3%)  
young Europeans (15–34) used cannabis in the last year and 9.6 
million of these (16.4%) are aged 15–24 years.  
• The most recent survey results show different trends 
in last-year cannabis use. Surveys for relatively high-
prevalence countries, such as Germany, Spain and the 
United Kingdom, all show decreasing or stable cannabis 
prevalence over the past decade, while France shows 
increases in prevalence after 2010. Countries which 
have historically reported lower cannabis use have seen 
increases in recent surveys. 
• Levels of lifetime cannabis use in 2013/14 among school-
aged children ranged from 5 per cent of girls and 7 per 
cent of boys in Sweden, to 26 per cent of girls and 30 per 
cent of boys in France.
• The number of first-time treatment entrants for cannabis 
as their main problem drug increased from 45,000 in 2006 
to 69,000 in 2014, with 55 per cent of these reporting daily 
use. 
• In 2014, 682,000 seizures of cannabis were reported in the 
European Union (453,000 of herbal cannabis, 229,000 of 
cannabis resin). There were a further  
33,000 seizures of cannabis plants. The quantity of 
cannabis resin, transported in large quantities and  
over long distances, seized in the European Union is much 
higher than that of herbal cannabis (574 tonnes versus 139 
tonnes).  
opioids (mainly heroin)
The number of clients reporting opioids as their primary drug 
when entering specialised treatment for the first time seems 
to have levelled off, dropping from 59,000 in 2007, when they 
accounted for 36 per cent of all new clients, to 23,000 in 2013 
(16% of new clients). Of the 185,000 opioid clients entering 
treatment in Europe in 2014, 34,000 were first-time entrants. 
• In 2014, 19 European countries reported that more than 10 
per cent of all opioid clients entering specialised services 
presented for problems primarily related to opioids other 
than heroin including methadone, buprenorphine, fentanyl, 
codeine, morphine, tramadol and oxycodone. 
• Among first-time clients entering drug treatment in 2014 
with heroin as their primary drug, 36 per cent reported 
injecting as their main route of administration, down 
from 43 per cent in 2006.
PREVALENCE AND CURRENT SITUATION 
European drug 
trends 2016
In May 2016 the European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA) published the European drug 
report 2016: trends and developments summarising the 
latest trends across the 28 EU member states, and Norway 
and Turkey.1 The report highlights the increasing use of MDMA 
following a period of decline in recent years, with greater 
levels of production helped by new sources of precursors 
and production techniques. The drug’s popularity with 
existing stimulant users has grown and a new generation of 
users is emerging, presenting greater health risks as more 
high potency products become available. 
The EU Early Warning System (EWS) reported 98 new 
substances, including 24 synthetic cannabinoids and 
26 synthetic cathinones. The growing number of new 
synthetic opioids is a cause for concern and may indicate 
that producers are targeting existing opioid users. Several 
deaths associated with NPS and stimulants have been 
reported in Europe but most of the 6,800 overdose deaths 
in 2014 were related to heroin and other opioids. Increased 
heroin availability, higher purity, ageing users and changing 
consumption patterns may be factors in this increase. Just 
over half of the 1.2 million people who received treatment 
for illicit drug use in the EU in 2014 received substitution 
treatment for opioid use.
Use of cannabis among young Europeans (15–34) does not 
appear to have fallen and there have been increases in 
use in some European countries. Potency levels of herbal 
cannabis are historically high, presenting health and social 
risks particularly to the one per cent of European adults who 
are estimated to be daily or almost daily users. The numbers 
of those entering treatment for the first time for whom 
cannabis is their main problem drug has increased steadily 
since 2006, indicating greater levels of use, more potent 
products and greater availability of treatment services.
At the launch of the report, Dimitris Avramopoulos,  
European Commissioner for Migration, Home Affairs  
and Citizenship, said: 
Europe faces a growing problem with drugs. New 
psychoactive substances, stimulants, heroin and other 
opioids continue to be in high demand and supply, 
with major impacts on public health. That is why the 
2016 European Drug Report is an important addition to 
our evidence base on the drugs problem and a helpful 
tool for European policymakers to shape policies and 
actions to address it. With this knowledge in hand, we 
will continue to call on EU Member State authorities, 
third countries, internet companies and civil society to 
redouble cooperation in fighting this global challenge.  
The situation described in the European drug report  
is presented below under a series of headings. The  
EMCDDA used the most recent data available to provide 
aggregate figures. 
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• The EMCDDA estimates that at least 6,800 overdose deaths 
occurred in the European Union in 2014, an increase from 
2013. 
• Viral hepatitis, particularly infection caused by the hepatitis 
C virus (HCV), is highly prevalent among injecting drug users 
across Europe, with six of the 13 countries with national 
data reporting a prevalence rate in excess of 50 per cent. 
Drug injection is a risk factor for other infectious diseases 
including hepatitis B, tetanus and botulism.
• The quantity of heroin seized within the European Union 
had been declining steadily from 2002 until 2013 when 5.6 
tonnes were seized. A total of 8.9 tonnes were seized in 
2014. The reversal in trends is largely due to an increase in 
large seizures (above 100 kg) in several countries.
 
Cocaine
• Cocaine is the most commonly used illicit stimulant drug in 
Europe, although its use is more prevalent in the south and 
west of Europe. It is estimated that about 2.4 million young 
adults aged 15 to 34 (1.9% of this age group) used cocaine 
in the last year. Only three countries report last-year 
prevalence of cocaine use among young adults aged 15 to 
34 of 3 per cent or more.
• The decreases in cocaine use reported since 2008 have 
not been observed in the most recent surveys; of the 
countries that have produced surveys since 2013, six 
reported higher estimates, two reported a stable trend 
and four reported lower estimates than in the previous 
comparable survey. 
• Overall, cocaine was cited as the primary drug by 59,000 
clients entering specialised drug treatment in 2014 and 
by 27,000 first-time clients. After a period of decline, the 
overall number of cocaine first-time treatment entrants 
has been stable since 2012.
• In 2014, almost 5,500 clients entering treatment in Europe 
reported crack cocaine as their primary problem drug, with 
the United Kingdom accounting for more than half of these 
(3,000), and Spain, France and the Netherlands most of the 
remainder (2,000).
• In the United Kingdom, deaths involving cocaine increased 
from 169 in 2013 to 247 in 2014. In Spain, where cocaine-
related deaths have been stable for some years, the drug 
continued to be the second most often cited drug in 
overdose deaths in 2013 (236 cases).
• In 2014, around 78,000 seizures of cocaine, amounting 
to 61.6 tonnes, were reported in the European Union. 
The situation has remained relatively stable since 2010, 
although both the number of seizures and the quantity 
seized are at levels considerably lower than in the peak 
years, 2006 –2008. 
other stimulants and new psychoactive 
substances
• Data on new psychoactive substances (NPS) are based on 
notifications by member states to the EU Early Warning 
System (EWS). In 2015, 98 new substances were reported 
for the first time (101 in 2014). Once again, the list of 
new substances reported was dominated by synthetic 
cannabinoids and synthetic cathinones (24 and 26 reported 
respectively). 
• In 2014, almost 50,000 seizures of new substances, 
weighing almost 4 tonnes (3,990 kg), were made across 
Europe. Together, synthetic cannabinoids and cathinones 
accounted for almost 80 per cent of the total number 
of seizures and over 60 per cent of the quantity seized 
during 2014. Other groups included non-controlled 
benzodiazepines and potent narcotic analgesics, such  
as fentanyls. 
• Some insights into the use of new drugs are provided by 
respondents to the 2015 Flash Barometer on young people 
and drugs, a survey of young adults aged 15–34, 8 per cent 
of whom reported lifetime use of these substances, with 
3 per cent reporting use in the last year. This represents 
an increase from the 5 per cent reporting lifetime use 
in a similar survey in 2011. Of those reporting use in the 
last year, 68 per cent had obtained the substance from a 
friend.
• Despite drug injecting having declined in Europe overall, 
stimulant injecting is now a concern. Nearly half (47%) of 
new clients entering treatment in 2014 with amphetamines 
as their primary drug reported injecting as their main route 
of administration.
• Latest survey data point to increased use of MDMA in 
Europe following a period of decline. Around 2.1 million 
young adults (15–34 years) report having used MDMA in the 
last year (1.7% of this age group). There are also signs that 
the drug is moving out of niche or sub-culture dance clubs 
into mainstream nightlife settings, such as bars and house 
parties.
 
Accompanying the European drug report are Perspectives 
on drugs (PODs), online interactive articles providing insights 
into specific issues in the drugs field. The three themes in 
focus this year are: cocaine trafficking to Europe, comorbidity 
of substance use and mental health disorders in Europe, 
and strategies to prevent diversion of opioid substitution 
treatment. 2
 Brian Galvin
1  European Monitoring Centre for Drugs and Drug Addiction 
(2016) European drug report 2016: trends and developments. 
Luxembourg: Publications Office of the European Union.  
http://www.drugsandalcohol.ie/25579/ 
2  For more information visit http://www.emcdda.europa.eu/edr2016
European drug trends continued
At the European Drug Report 2016 launch in Lisbon: Dimitris 
Avramopoulos, European Commissioner for Migration, Home 
Affairs and Citizenship and Alexis Goosdeel (director) and Rosemary 
Martin de Sousa (head of communications) of the EMCDDA
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• Cocaine powder, ecstasy and ketamine were the next 
most commonly used drugs, with benzodiazepines and  
Z drugs being used to a lesser extent.
• Service providers reported an increase in the use of 
these drugs by untreated young drug users aged between 
15 and early 20s.
• Ecstasy has made a ‘resurgence’ in terms of popularity.
• Ketamine has become increasingly popular over the last 
twelve months.
• Poly-drug use was perceived to be the norm, occurring 
at weekends among young people aged 15 and over.
• Alcohol was reported to be a fundamental part of poly-
drug use. A typical drug-taking session started with 
alcohol and was then accompanied by other drugs.
• The frequency of poly-drug use was dependent on the 
age of the drug user, with those aged 18–30 reporting 
more regular polydrug use.
Speaking at the launch Jim Doherty, BLDATF Coordinator, said:
Decisions on how to spend the Task Force budget 
have to be made on the best available evidence 
of what the needs of the community are. If this 
evidence isn’t already being gathered then the Task 
Force has to do this job itself. This is what we have 
done, using the best methods known and asking the 
community what the issues are. We also intend to 
keep on doing it on a regular basis, so that we are 
never out of touch with the community we serve.
vivion McGuire
1  Blanchardstown Local Drugs and Alcohol Task Force (2016)  
Drug and alcohol trends monitoring system (DATMS) 2016. 
Dublin: Blanchardstown Local Drugs and Alcohol Task Force. 
www.drugsandalcohol.ie/25281/ 
Drug and 
alcohol trends in 
Blanchardstown
On 8 March 2016 Blanchardstown Local Drugs and Alcohol 
Task Force (BLDATF) launched its Drug and alcohol trends 
monitoring system (DATMS) 2016.1
BLDATF developed the DATMS to provide up-to-date 
information about drug and alcohol use among people living 
in Dublin 15. The monitoring system identifies the types 
of drug being used within the local community, and also 
identifies emerging trends at an early stage of development. 
To gather the relevant data, clients of treatment services 
were interviewed and outreach workers administered 
questionnaires in the local community.
This type of information is necessary in order to recognise 
key local issues and to develop appropriate strategies in 
response. The data will serve as a baseline for local trends 
from which future variations can be monitored over time.
Key research findings for treated drug  
and alcohol use
• The main problem drugs for which adult drug users 
sought treatment included heroin, methadone, alcohol, 
cannabis (weed), benzodiazepines, Z drugs and cocaine 
powder.
• The main problem drugs for which under-18-year-old 
drug users sought treatment included cannabis (weed) 
and alcohol. Ecstasy and solvents were involved to a 
lesser extent.
• Service providers reported an increase in the use of the 
following drugs by treated drug users: cannabis (weed), 
benzodiazepines and Z drugs, crack cocaine, alcohol, 
Lyrica/Pregabalin (prescribed pain killer) and codeine-
based over-the-counter (OTC) drugs. 
• The increase in the use of weed related to both treated 
under-18 and adult drug users. The increase in the use of 
the other drugs is related to treated adult drug users only.
• The number of heroin users entering treatment is in 
decline; clients are an ageing population of long-term 
users, with fewer young people accessing treatment.
• Poly-drug use was reported to be the norm by the 
majority of both treated under-18 and adult drug users.
• Steroid use by some men in recovery from problematic 
drug use was associated with relapse.
Key research findings for untreated drug  
and alcohol use
• Alcohol was the most commonly used drug, with binge 
drinking being a common occurrence among both males 
and females.
• Cannabis (weed) was the second most commonly used 
drug; among young people frequency of use varied 
from daily to less frequent use, with some young males 
reporting daily use before and during school.
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Of the 20 for whom injecting information was available,  
18 reported recent injecting of ‘Snow Blow’. Twenty reported 
having sex with a person who injected drugs or  
with an HIV-positive partner. 
 
For the case-control study, 15 of the reported cases were 
recruited. A random sample of 39 HIV-negative, homeless, 
chaotic drug users were recruited from the National 
Drug Treatment Centre as a control group. There was no 
difference between cases and controls in age, duration of 
injection or living circumstances. 
The study found that compared with the controls, 
the cases were more likely to have reported injecting 
methamphetamine and Snow Blow, and using amphetamines, 
other head shop drugs or benzodiazepines. Cases were also 
more likely to have reused needles or syringes, and to have 
had sex with partners who inject drugs.
Multivariate logistic regression was used to determine  
which of these factors were associated with HIV infection. 
The factor with the strongest association with HIV infection 
was injecting Snow Blow. However, being female, reusing 
needles and syringes and having sex with a partner who 
injects drugs were all independently associated (see Table 1).
HIv infection among 
homeless people 
who inject drugs
A paper published in September 2015 outlines a case-
control and epidemiological study conducted in response 
to an increase in recently acquired HIV infection among a 
population of homeless people who inject drugs (PWID) in 
Dublin.1 The report defines recently acquired HIV infections 
as those in which the person who tests positive is p24 
antigen, or has had an HIV negative test within the previous 
12 months, or suffers an acute HIV sero-conversion illness. 
Clinicians in the drug treatment services were concerned 
that the increase might be linked to injection of a synthetic 
cathinone PVP, with the street name ‘Snow Blow’, which  
was being used by homeless drug users. In response,  
an epidemiological investigation and case-control study  
were instigated.
Between 2014 and 2015, 38 confirmed or probable cases of 
recently acquired HIV were reported (see Figure 1). Of these, 
16 were female, the median age was 35 years (range 24–51) 
and 29 were registered homeless. 
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Figure 1: Recent HIV infections with epidemiological link to PWID in Dublin,  
by month of first diagnosis, January 2014 to September 2015 (n=38)
Table 1: Factors positively associated with recent HIV infection in multiple regression analysis
Factors positively associated with recent HIV infection Adjusted odds ratio 95% Confidence Interval P value
Injecting Snow Blow 49 3.6 – 669 0.003
Reusing needles/ syringes 13 1.01 – 177 0.049
Having sex with PWID 36 1.6 – 782 0.022
Female sex 3.5 0.27 - 44 0.34
Source: Giese C et al.1
Source: Giese C et al.1
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In response to the increased incidence of HIV, the authors 
report that the following control measures were immediately 
implemented:
• provision of antiretroviral therapy to PWID diagnosed 
with HIV, where possible, and contact tracing to detect 
any additional cases among sexual or drug-sharing 
partners;
• review of clients attending drug services, to identify 
those most at risk, and offering urgent HIV testing;
• pilot point-of-care testing (POCT) of PWID clients 
attending Safetynet homelessness services (Safetynet is a 
networking organisation for nurses, doctors and voluntary 
agencies providing primary health care to homeless 
people in Dublin, Cork and Galway);
• enhanced surveillance to identify new HIV cases as early 
as possible, including mode of transmission;
• awareness-raising among clients, clinicians, networks of 
PWID and other stakeholders;
• provision of greater access to needle exchange and other 
preventive activities within the drugs services, homeless 
hostel services and prisons (the need for additional 
measures, including extended opening hours for needle 
exchanges, is being evaluated); 
• development and distribution of communications 
material, aimed at raising awareness of the risk of HIV 
posed by unsafe injecting and unsafe sex (available on 
the website of the Health Protection Surveillance Centre 
[HPSC]); and
• active case finding including Recent Infection Testing of 
possible cases, and phylogenetic analysis of cases.
Margaret Curtin
1 Giese C, Igoe D, Gibbons Z, Hurley C, Stokes S, McNamara S, 
Ennis O, O’Donnell K, Keenan E, De Gascun C, Lyons F, Ward 
M, Danis K, Glynn R, Waters A and Fitzgerald M (2015) ‘Injection 
of new psychoactive substance snow blow associated with 
recently acquired HIV infections among homeless people 
who inject drugs in Dublin, Ireland, 2015’. Euro surveillance: 
bulletin Européen sur les maladies transmissibles = European 
communicable disease bulletin 20(40): Euro Surveill. http://
www.drugsandalcohol.ie/25015/
HIv infection among  
homeless PWID continued
episodes occurring on these two days. There was evidence of 
alcohol consumption in 3,860 (35%) presentations and this 
was more common among men (37%) than women (33%). 
Drug overdose was the most common form of deliberate 
self-harm reported in 2014, occurring in 7,314 (66%) 
episodes. This was a small decrease (-2%) on 2013. Overdose 
rates were higher among women (72%) than among men 
(58%). In 70 per cent of cases the total number of tablets 
taken was known, with an average of 28 tablets taken in 
these episodes. 
A minor tranquilliser (most commonly benzodiazepines) was 
involved in 37 per cent of all drug overdoses; 28 per cent 
of overdoses involved paracetamol-containing medicines; 
21% involved antidepressants or mood stabilisers (most 
commonly selective serotonin reuptake inhibitors [SSRIs]);  
10 per cent involved a major tranquilliser; and 26 per cent 
other prescribed drugs. 
There was an 11 per cent increase in the number of 
presentations involving street drugs, from 420 in 2013 to  
465 in 2014 (following annual decreases from 2010 to 2013). 
The 2014 level was similar to the level recorded in 2008 – 461.
The next steps, or referral outcomes, for the deliberate 
overdose cases were 51 per cent discharged home; 28 per 
cent admitted to an acute general hospital; six per cent 
admitted to psychiatric in-patient care; a small proportion 
(1%) refused admission to hospital; and 14 per cent 
discharged themselves before receiving referral advice. 
The report provides information on what was being or 
could be done to reduce the number of self-harm cases. 
Particularly encouraging were the facts that over 30 self-
harm specialist nurses had taken up positions in various 
hospitals in 2014 and that increased numbers of patients 
were receiving mental health assessments. 
National Registry of 
Deliberate Self-Harm 
– Annual Report 2014 
The 13th annual report from the National Registry of 
Deliberate Self-Harm was published in September 2015.1 
The report contains information relating to every recorded 
presentation of deliberate self-harm to acute hospital 
emergency departments in Ireland in 2014, and complete 
national coverage of cases treated. All individuals who were 
alive on admission to hospital following deliberate self-harm 
are included, along with the methods of deliberate self-harm 
that were used. Accidental overdoses of medication, street 
drugs or alcohol are not included.
There were 11,126 recorded presentations of deliberate 
self-harm, involving 8,708 individuals, in 2014. This implies 
that more than one in five (2,418, 22%) of the presentations 
were repeat episodes. There was virtually no change in the 
rate of presentations between 2013 and 2014, following a six 
per cent decrease between 2012 and 2013. The rate in 2014 
remained six per cent higher than the pre-recession rate of 
188/100,000 in 2007 (Figure 1). The only age group in which 
there was significant change in the rate of deliberate self-
harm between 2013 and 2014 was boys aged 10 to 14 years, 
among whom the rate increased by 44 per cent, from 34 to 
49 per 100,000. 
Forty-six per cent of self-harm presentations in 2014 were 
men, and just over half (54%) were aged under 30 years. 
People living in hostels for the homeless or of no fixed abode 
made up five per cent (n=514) of self-harm presentations. 
Presentations peaked in the hours around midnight and 
were highest on Sundays and Mondays, with 31 per cent of 
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The authors report that there was variation in the next care 
recommended to deliberate self-harm patients, and in the 
proportion of patients who left hospital before receiving 
a recommendation. While overall, nearly three quarters 
of all patients were discharged with a referral, variations 
were seen in referral pathways across HSE hospital groups. 
The authors recommend that the national guidelines for 
the assessment and management of patients presenting 
to Irish emergency departments following self-harm be 
implemented nationally as a matter of priority. 2
The report highlights the on-going work by the National 
Suicide Research Foundation to link data on deliberate self-
harm with suicide mortality data. This linking has shown that 
individuals who self-harm are over 42 times more likely to 
die by suicide than the general population. Further linkage is 
recommended in order to enhance insight into predictors of 
suicide risk.
Margaret Curtin
1  Griffin E, Arensman E, Dillon CB, Corcoran P, Williamson E and 
Perry IJ (2015) National self-harm registry Ireland annual 
report 2014. Cork: National Suicide Research Foundation. http://
www.drugsandalcohol.ie/24654/ 
2  Cassidy E, Arensman E, Keeley HS and Reidy J ((2012) Saving 
lives and reducing harmful outcomes: care systems for self-
harm and suicidal behaviour. Dublin: HSE, and Cork: National 
Suicide Research Foundation. https://www.hse.ie/eng/about/
Who/clinical/natclinprog/mentalhealthprogramme/selfharm/
selfharm.pdf 
While the total number of presentations involving drug 
overdose rose, there was a significant reduction in overdoses 
involving minor tranquillisers. The report relates this to 
proactive monitoring of prescribing patterns in primary care 
services since 2012. The authors recommend that reducing 
access to minor tranquillisers should be an on-going priority. 
The authors report that, as in previous years, alcohol 
continued to be one of the factors associated with the 
higher rate of self-harm presentations on Sundays, Mondays 
and public holidays, and in the hours around midnight. These 
findings underline the need for on-going efforts to:
• enhance health service capacity at specific times and 
increase awareness of the negative effects of alcohol 
misuse and abuse such as increased depressive feelings 
and reduced self-control;
• intensify national strategies to increase awareness of the 
risks involved in the use and misuse of alcohol, starting at 
pre-adolescent age, and intensify national strategies to 
reduce access to alcohol and drugs; 
• educate self-harm patients and their families about the 
importance of reduced use of and access to alcohol; and 
• arrange active consultation and collaboration between the 
mental health services and addiction treatment services 
in the best interest of patients who present with dual 
diagnosis (psychiatric disorder and alcohol/drug abuse). 
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Figure 1: Person-based rate of deliberate self-harm, 2002–2014, by gender
Source: Griffin E et al.1 
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16 depression and schizophrenia. Two had personality disorders. 
Full details of the demographics, substance use, mental 
health status and co-morbidities of the 20 most frequent 
attenders are provided in Table 1.
The authors point out that a small number of repeat 
attenders may be responsible for a disproportionate level of 
emergency department attendances. These repeat attenders 
generally have substance misuse and psycho-social issues. 
Moreover, the authors highlight the burden of alcohol and 
drug dependence on the Irish health services and state that 
in 2007, €1.2 million was spent on alcohol-related illnesses. 
The authors also highlight the high incidence of mental 
health problems among frequent attenders and propose that 
this may be due to insufficient community-based mental 
health services. They conclude that frequent attenders are a 
complex group needing a holistic multi-disciplinary approach 
that would involve addressing underlying issues such as drug 
and alcohol dependency, mental health issues and social 
deprivation, with significant investment outside the hospital 
setting to relieve pressure on emergency departments.
Margaret Curtin
1  Ramasubbu B, Donnelly A and Moughty A (2016) Profile 
of frequent attenders to a Dublin inner city emergency 
department. Irish Medical Journal (109/4).  
http://www.drugsandalcohol.ie/25379/ 
Frequent attenders 
at a Dublin inner-
city emergency 
department
A recently published paper retrospectively examined the 
demographics, substance use, mental health and co-
morbidities of the 20 most frequent attenders at the Mater 
Misericordiae University Hospital in 2014.1 
The study found that the majority (17) of the 20 most 
frequent attenders were male, all were unemployed and the 
median age was 38.5 years (range 21 to 59). Seven were of no 
fixed abode and a further five were living in temporary hostel 
accommodation. Nineteen were either single or separated. 
Among the 20, 16 misused either drugs or alcohol: 10 were 
current illicit drug users, six had a benzodiazepine addiction, 
three a heroin addiction, and one was polydrug dependent. 
The average attendance rate by illicit drug users was twice 
that of non-drug users. The majority (12) were alcohol 
dependent, with a further two reporting alcohol abuse. 
Seventeen were smokers. Thirteen had mental health issues, 
four of these had depression and a further four had both 
Table 1: Demographics, substance misuse and co-morbidities of the 20 most frequent emergency department attenders,  
Mater Misericordiae University Hospital, 2014 
Attendances (n) Gender Age Drug  
Misuse
Alcohol 
Misuse
Mental Health 
Issues
Co-morbidities Marital 
status
Living 
arrangement
404 m 37 Benzodiazepines Dependence Yes Gastritis Single Hostel
120 m 39 Heroin Dependence Yes Hepatitis B Single No fixed abode
101 m 24 Benzodiazepines Dependence Yes Nil Single Hostel
91 f 21 Benzodiazepines No Yes Epilepsy Single Own residence
91 m 52 Nil Dependence Yes Peptic Ulcer Divorced No fixed abode
81 m 38 Heroin Dependence Yes Hepatitis C Single No fixed abode
80 m 58 Nil Dependence No Nil Single No fixed abode
64 f 46 Benzodiazepines No Yes COPD Separated Own residence
62 m 27 Nil No Yes Nil Single No fixed abode
50 m 38 Nil Dependence Yes Asthma Single Hostel
49 m 26 Polydrug Dependence Yes Nil Single Own residence
43 m 42 Nil Dependence No Liver Cirrhosis Separated Hostel
41 f 25 Benzodiazepines Abuse Yes Nil Single Hostel
39 m 56 Nil Dependence Yes Liver Cirrhosis Single Own residence
39 m 46 Benzodiazepines Dependence Yes Pancreatitis Single Own residence
38 m 51 Heroin Dependence No Hepatitis C Civil 
Partnership
Own residence
37 m 37 Nil No No Chronic renal 
failure
Single Own residence
36 m 36 Nil Abuse No Deaf, 
congenital 
heart disease
Single No fixed abode
35 m 54 Nil No No Asthma Single No fixed abode
35 m 59 Nil No No COPD Widowed Own residence
Source: Ramasubbu B et al.1
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and its neighbours, Africa and the Middle East. Volatility 
and nearness to Syria have led to the development of 
a ‘geographical hotspot of multiple and potentially 
interconnected threats’ such as drug and other organised 
crime and human relocation. 
The risk factors associated with drug crime and with 
radicalisation are considered to overlap, for example 
disadvantaged individuals are at greater risk of being 
imprisoned for drug offences, and prison is a setting known 
to contribute to radicalisation. The report points out that 
because terrorism and drugs are viewed as separate entities, 
knowledge gaps are extensive and links between the two 
areas are often missed. 
Government institutions and corruption
In the majority of EU states, a large proportion of drug-
related public expenditure is used to try to reduce drug 
supply. Nonetheless, there is often pressure to reassign 
funds to address other issues considered more urgent.  
In addition, the power of governments can be damaged by 
corruption and coercion, for example in the judiciary or 
within law enforcement agencies.
Impacts on wider society and global stabilisation efforts
Society is affected by the operation of drug markets in a 
variety of ways, from increased acquisitive crime owing 
to addiction, to homicide, or feeling unsafe living in an 
area. In addition, in areas where drugs are produced, the 
environment may be directly affected by chemicals used 
during production, deforestation or erosion, and indirectly, 
depending on the location, by migration, destabilisation  
and climate change.
Main drug markets
 
The report examines the drug markets related to the main 
drug types and provides insights into their development from 
production through to supply. Key features of these markets 
include their global spread, the involvement of OCGs, the 
trafficking routes and the retail markets. Based on the most 
recent available figures up to 2015, the most prominent drug 
in Europe’s illicit drug retail markets is cannabis, followed by 
heroin and then cocaine.
New psychoactive substances (NPS)
Although NPS are a relatively new addition to the EU 
drug market, their importance and growth cannot be 
overestimated. In 2015, 100 new substances were identified 
by the EMCDDA and approximately 650 were being 
monitored. As a result of the ‘rapidly changing nature’ of 
these substances, it is difficult to estimate NPS consumption. 
The report points out that the same brand name may be 
used for completely different substances, resulting in 
individuals not being aware of what they are taking. 
The 2014 Eurobarometer Survey, which examined the use 
of NPS among 15–24-year-olds across EU member states,3 
indicated that overall eight per cent of respondents 
reported using NPS, of whom one per cent reported using in 
the last 30 days, three per cent in the previous 12 months, 
and four per cent more than a year ago. Broken down by 
country, the highest level of NPS consumption was reported 
by Irish young people (22%). This figure illustrates that NPS 
consumption in Ireland has increased by six per cent since 
the 2011 Eurobarometer Survey (16%).4 
EU drug markets 
report 2016
On 5 April 2016 the European Monitoring Centre for Drugs 
and Drug Addiction (EMCDDA) and Europol published their 
second joint study of European drug markets.1 This in-depth 
strategic examination builds on the 2013 report, which 
was the first attempt to bring together intelligence on the 
functionality and structure of European drug markets in the 
wider illicit drugs setting.2 The overall aim of both reports 
has been to inform policy and responses aimed at drug 
supply reduction. 
The recent report focuses on three areas. Firstly, it 
examines the consequences of the illicit drug market 
and what drives its development. Secondly, it examines 
the main drug markets, such as cannabis, heroin 
and other opioids, cocaine, methamphetamine and 
methylenedioxymethamphetamine (MDMA), and new 
psychoactive substances (NPS). Each chapter recommends 
actions which highlight areas that should continue or need 
to be addressed. Finally, the report examines policies and 
responses aimed at reducing the supply of illicit drugs. 
Consequences of the illicit drug market
 
Legal economy 
The illicit drug market has a broad impact, not just on 
individuals who use drugs but also on society as a whole.  
A number of impacts are identified in the report.
A challenge for organised crime groups (OCGs) is moving 
money that has been generated via illicit drug dealing into 
circulation. This has an impact on the legal economy as 
legitimate businesses are necessary to launder the cash, 
and they are at risk of being linked with ‘trade-based money 
laundering schemes’.
Wider criminal activity
OCGs have been shown to be increasingly adaptable and 
flexible in their operational activities and interactions, and 
hence the opportunities to act illegally are immense. The 
ability of law enforcement agencies to fill the knowledge 
gaps about these interactions is viewed as essential. The 
report highlights three such knowledge gaps that represent 
‘intelligence-gathering opportunities’:
• drug supply carried out alongside other activities, for 
example firearms or migrant smuggling;
• drug supply that funds other crimes, for example 
terrorism or exploitation of people; and
• other crimes committed when dealing drugs, for example 
forcing trafficked individuals to take part in producing 
and selling drugs.
terrorism
Links exist between OCGs engaged in drug trafficking and 
terrorist groups. These interactions are functional in that 
terrorists appear to avail of the drug markets as a way of 
funding other activities. From a European perspective, this 
link is viewed as a ‘threat’ as it has resulted in renewed 
interest in producing opium and other drugs in Afghanistan 
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16 • social factors that result in people getting involved 
in producing and selling drugs, for example human 
trafficking, exploitation as a result of poverty, and 
immigration.  
 Ciara Guiney
1  European Monitoring Centre for Drugs and Drug Addiction, 
Europol (2016) EU drug markets report: in-depth analysis. 
Luxembourg: Publications Office of the European Union.  
http://www.drugsandalcohol.ie/25357/ 
2  European Monitoring Centre for Drugs and Drug Addiction, 
Europol (2013) EU drug markets report: a strategic analysis. 
Luxembourg: Publications Office of the European Union.  
http:// www.drugsandalcohol.ie/19227/
3  TNS Political and Social (2014) Flash Eurobarometer 401.  
Young people and drugs. Luxembourg: European Commission. 
http://www.drugsandalcohol.ie/22196/ 
4  The Gallup Organization (2011) Youth attitudes on drugs. Flash 
Eurobarometer 330 Analytical report. Luxembourg: European 
Commission. http://www.drugsandalcohol.ie/15497/ 
Policies and responses 
The final chapter of the report examines policies and 
strategies aimed at reducing drug supply. The main strategic 
action highlighted is the EU drugs strategy (2013–20) and 
action plan (2013–16). The framework in this strategy 
and action plan are considered to mirror the challenges 
identified in the report. The report outlines the roles played 
by different EU institutions and agencies in the development 
and application of the EU’s drugs policy. 
The report highlights three areas of the drug market that are 
being targeted:
• organisations involved at national and international 
level in the production and supply of drugs, for example 
OCGs which are multifaceted, particularly in the areas 
of organisational structure, technical knowledge, 
connections with other organisations and areas of 
specialism;
• factors that enable drug activities, for example 
money, help from other professionals, and advances in 
globalisation and technology; and
EU drug markets continued
Non-recording of crimes 
Twenty per cent of validated crimes (e.g. assault, burglary, 
criminal damage, public damage, robbery, theft) and 23 per 
cent of non-crimes (e.g. bomb scares, domestic disputes/ 
domestic violence and sexual assault) reported on CADs 
were not reported on PULSE. In addition, 16.4 per cent of 
validated paper records were not reported on PULSE. The 
authors advised caution when interpreting these results as it 
was challenging to match records between CAD and PULSE, 
hence some records deemed not to be on PULSE  
may actually be there. 
Lack of timeliness in recording crimes 
Within the PULSE system a creation date and report date 
are recorded. The CSO found that following a crime being 
reported, there was a delay of over a week before seven per 
cent of incidents were recorded on PULSE.
Alteration of narratives 
The narrative field on PULSE, which records details of a 
crime, can be amended as further information becomes 
available. To determine whether narratives had been edited 
to justify classification decisions, the narrative lengths of all 
incidents were analysed to see if any reductions in length 
had taken place between the January 2012 dataset and 
the April 2014 dataset, which would indicate unacceptable 
editing. Not a single case was identified. 
As it was not possible to establish what records had been 
amended before January 2012, the audit trails for a sample 
of 500 PULSE criminal records were examined. The audit trail 
records every change to the narrative, the date and time 
of the change and who made the change. Only one of the 
500 records (a reclassified crime case) revealed evidence 
that an alteration had been made to justify an incorrect 
reclassification.
the quality of  
crime statistics
Since 2003 the production of crime statistics has been the 
responsibility of the Central Statistics Office (CSO). These 
statistics are based on data collated by An Garda Síochána 
using the Garda PULSE (Police Using Leading Systems 
Effectively) system. 
In 2014 a report produced by the Garda Inspectorate 
drew attention to serious problems regarding the 
recording of crime on PULSE.1 Issues included the non-
recording of crimes, lack of timeliness in recording crimes, 
misclassifying crime incidents and non-crime incidents at 
initial stages, incorrect reclassification of incidents, and 
incorrect application of detection and invalidation status 
to certain crimes. 
Given that the CSO draws on PULSE data to produce crime 
statistics, it was considered essential to carry out a review of 
the data received by the CSO to determine their accuracy.2 
The aim of the review was to determine how many legitimate 
offences were not being recorded on the PULSE system. 
Access was provided by the Garda Síochána to crime and 
non-crime data including CAD (Command Aided Dispatch), 
paper records and non-crime PULSE incident groups, such 
as Attention and Complaints, Property Lost and Domestic 
Dispute. A random selection of CAD and paper records was 
checked against corresponding records on PULSE. What 
follows is a summary of the main findings. 
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Incorrect application of invalidation status 
Invalidation occurred when there was no crime or when 
‘counting rules’ were wrongly applied. Out of 528 invalidated 
records, 23.1 per cent were unjustified. The highest 
proportions of unjustified invalidations was shown for 
‘Robbery, Extortion and Hijacking Offence’ (18.9%; n=32)  
and ‘Sexual Offences’ (43.3%; n=26).
Conclusions/Recommendations
The CSO estimated the impact of the problems identified in 
their review. The largest percentage increases were 38 per 
cent in Group 03 (Attempts, Threats to Murder, Assaults, 
Harassments and Related Offences), 27 per cent in Group 08 
(Theft and Related Offences) and 26% in Group 09 (Fraud, 
Deception, and Related Offences). Alterations owing to 
misclassifications within groups were not considered, for 
example Assault Causing Harm and Assault Minor are both in 
Group 03.
Consistent with the Garda Inspectorate report, the CSO 
review found discrepancies between crimes recorded 
on CAD/Paper and PULSE. The CSO made a number of 
recommendations to improve the quality of the data.  
• The introduction of a unique identifying number between 
CAD/Paper reports and PULSE would enable data to be 
linked more effectively, and allow greater accuracy and 
quality control. 
• The crime narrative should match subsequent crime 
classification, detection and/or invalidation status 
recorded. 
• The decision-making process in PULSE should be 
centralised. This would ensure operational procedures 
were followed with regard to crime and non-crime 
classification, reclassification, detection and/or 
invalidation. 
Ciara Guiney
1  Garda Inspectorate (2014) Report of the Garda Síochána 
Inspectorate. Crime investigation. Dublin: Garda Inspectorate. 
http://www.drugsandalcohol.ie/22967/ 
2  Central Statistics Office (2015) Review of the quality of  
crime statistics: Dublin: Government of Ireland.  
http://www.drugsandalcohol.ie/24887/ 
Misclassification of incidents 
There are approximately 300 crime classifications on PULSE. 
How crimes are classified is essential for accurate reporting.
The CSO focused on six classifications of serious crimes – 
Assault Minor, Assault Causing Harm, Criminal Damage (Not 
Arson), Theft from Person, Burglary, and Robbery from the 
Person. The analysis indicated that three per cent of records 
were classified incorrectly and the classification of a further 
four per cent was unclear.
To determine whether non-crime incidents should have 
been classified as crimes, narratives from Attentions and 
Complaints (n=1,000), Property Lost (n=500) and Domestic 
Dispute (n=300) were examined. Although the majority 
of records were classified correctly (91%–94%), a small 
number of records were either misclassified (4%–7%) or 
unclear (4%–7%). Further analysis indicated that 69 records 
from Attention and Complaints should have been in Assault 
or Fraud/Threatening Letters and one in Sexual Assault/
Robbery; 18 Property Lost should have been in Theft; and 
13 Domestic Disputes should have been in Assault or Assault 
causing Harm.
Incorrect reclassification of crime incidents
Crime classifications were compared on PULSE between 
January 2012 and January 2013. Three areas were examined: 
Assault (n=57), Assault Causing Harm (n=12) and Criminal 
Damage (n=189). The analysis indicated that 71 per cent 
of reclassifications were justified whilst 15 per cent were 
not. A further analysis of ‘downgrades’ in the Assault and 
Assault Causing Harm categories indicated that 51 per cent 
were justified and 26 per cent were not. Approximately 50 
per cent of crimes were upgraded and 15 per cent were 
reclassified down in the Criminal Damage category. Within 
this category, the highest proportion of reclassifications 
occurred for Burglary (44%), followed by Theft (35%). 
In non-crime categories, for example Attention and 
Complaints, Burglary and Related Offences (19%) and Theft 
and Related Offences (12%) were reclassified. A limitation of 
this analysis was that data from PULSE were only received by 
the CSO at the end of every month; hence the CSO was not 
privy to reclassifications that occurred when the crime was 
originally reported. 
Incorrect application of detection status 
To determine whether ‘detected’ crimes resulted in criminal 
proceedings, 138,807 ‘detected’ crimes were examined, 
54 per cent were linked to a charge or summons whereas 
46 per cent were not. A further analysis of the accuracy of 
‘detection rules’ on ‘detected’ crimes with no charge or 
summons (n=500) indicated that over a third of crimes were 
wrongly assigned ‘detected’ (35 per cent ). This accounted 
for a 16 per cent (22,307) reduction in the total number of 
‘detected’ crimes.
Crime statistics continued
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16 Not everyone can be helped through the DDTC. Broomfield 
points out that the combination of drug dependency, crime 
and other difficulties such as coming from a disadvantaged 
socio-economic background or a dysfunctional family 
background (e.g. drug-abusing parents or siblings), 
homelessness or mental illness, result in challenging 
environments for addiction treatment, making it necessary 
to adapt interventions accordingly. 
Completers
Two separate evaluations of the effectiveness of the DDTC 
have indicated that the number of completers was low but 
offending behaviour had declined. A review in 2002 gained 
insights from completers regarding the DDTC process, and 
the pros and cons of sticking with the programme.8 No 
information was reported on attitudes or quality of life 
changes or on the progress of non-completers. A second 
review in 2010 aimed to determine why referrals were 
low and to identify how ‘increased throughput’ could be 
attained.9 As in 2002, the main finding was the low number 
of completers; again, the progress of non-completers was 
not considered. Broomfield argues that it is concerning that 
evidence about participants in the 2010 evaluation appears 
to have been obtained from professionals rather than 
participants themselves.
Drawing on the work of Butler,10 who examined how the 
DTC policy transferred from the USA to Ireland, Broomfield 
notes that (1) the development of the DTC in Ireland was 
politically driven; (2) therapeutic jurisprudence (an active, 
problem-solving judiciary) and the ability to buy addiction 
treatment evident in the US were not present in the Irish 
system; (3) although professionals viewed participation as 
beneficial, they were uncertain that credit for the positive 
outcomes should be attributed to the DDTC; and (4) 
disparities were evident in the socio-economic backgrounds 
of participants in the US and in Ireland – Irish participants 
were economically deprived and addicted to opiates while 
American participants were more affluent.
Non-completers
Research on DTCs has focused on completers, which could 
suggest that non-completers are failures. To redress this 
gap, grounded theory has been used to examine the benefits 
(including intention-to-treat and harm reduction) of the DTC 
programme for non-completers.11 
A significant harm reduction effect was identified, which 
led the authors to conclude that the provision of a harm 
reduction model alongside the abstinence-based model would 
be beneficial. Despite the limited sample size, Broomfield 
argues that this research has provided valuable insights.
RESPONSES 
Drug treatment 
courts
Studies carried out in Ireland suggest that the majority of 
offenders detected in Ireland present with some form of 
drug dependency.1,2,3 The study reported on here evaluates 
one approach that has been used within the justice system 
to treat drug dependency – drug treatment courts (DTCs).4
origins
Broomfield describes how DTCs emerged in the United 
States (US) in response to the growing drug crisis in the 
1980s. According to Broomfield, the DTC model brings 
together the ‘powers of court’ and drug treatment, with the 
aim of supporting steps to sobriety via regular contact with 
the user, monitoring substance use, evaluating responses to 
interventions and close supervision. Studies evaluating the 
effectiveness of DTCs in the US suggest that: 
• reoffending and drug dependency are lower among DTC 
participants,
• progress is impacted by ‘severity of misuse’, previous 
history, and use of stimulants,
•  programme completion was higher in users receiving 
pharmacotherapy, and 
•  more completions occurred when the presiding judge 
was there longer and when the court was smaller.5
However, Broomfield notes that other reviews provide 
evidence contradicting these findings. When pre-trial release 
and drugs testing were compared with parole and probation, 
effect sizes demonstrated that the latter were better.6 
Another review suggested that the impact of diversions 
reducing drug dependency was small.7 
Dublin DtC
The Dublin DTC (DDTC) pilot programme started in 2001. 
Similar to the US DTC, the aim was to reduce offending and 
drug dependency with help from addiction nursing, education 
and probation supervision. There were three stages: bronze, 
silver and gold. Participants were required to: 
• attend court regularly (weekly, fortnightly or monthly),
•  attend education programmes daily,
• meet with a probation officer regularly, and 
•  engage in treatment relating to their drug of choice.
During the programme, progress was reviewed by the 
DDTC judge. Following successful completion of the DDTC, 
charges were ‘struck out’. Broomfield casts doubts on the 
merits of using completion rewards, in particular for those 
with extensive offences, no desire to travel or live abroad, 
or those who were not afraid of having a criminal record. 
Despite this, he argues that the DDTC programme provides a 
structure which can reduce destructive behaviour. 
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3.   Martyn M (2012) Drug and alcohol misuse among adult 
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and Alcohol Survey 2011. Irish Probation Journal (9): 75–93. 
http://www.drugsandalcohol.ie/21636/ 
4.   Broomfield D (2015) Drug treatment courts: refining successes 
and failures through participant narratives. The Irish Social 
Worker (Spring): 36–40. http://www.drugsandalcohol.
ie/24713/
5.   Brown RT (2010) Systematic review of the impact of adult 
drug-treatment courts. Translational Research (155/6): 
263–274. Retrieved 9 June 2016 http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC2886018/pdf/nihms190930.pdf 
6.   Perry AE, Darwin Z, Godfrey C, McDougall C, Lunn J, Glanville 
J et al. (2009) The effectiveness of interventions for drug-
using offenders in the courts, secure establishments and 
the community: a systematic review. Substance Use & 
Misuse (44/3): 374–400. Retrieved 9 June 2016 http://www.
tandfonline.com/doi/full/10.1080/10826080802347560 
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al. (2015) The effectiveness and cost-effectiveness of diversion 
and aftercare programmes for offenders using class A 
drugs: a systematic review and economic evaluation. Health 
Technology Assessment Database (Internet). (2). Retrieved 9 
June 2016 http://onlinelibrary.wiley.com/o/cochrane/clhta/
articles/HTA-32011000672/frame.html
8.   Farrell M (2002) Final evaluation of the pilot drug court. 
Dublin: Courts Service. Retrieved 9 June 2016 http://
www.justice.ie/en/JELR/finalevalpilotdrug.pdf/Files/
finalevalpilotdrug.pdf 
9.   Department of Justice, Equality and Law Reform (2010) Review 
of the drug treatment court. Dublin: Department of Justice, 
Equality and Law Reform. http://www.drugsandalcohol.
ie/13113/ 
10.  Butler S (2013) The symbolic politics of the Dublin 
drug court: the complexities of policy transfer. Drugs: 
Education Prevention and Policy (20/1): 5–14. http://www.
drugsandalcohol.ie/18888/
11.   Francis TR and Able EM (2014) Redefining success: a qualitative 
investigation of therapeutic outcomes for noncompleting 
drug court clients. Journal of Social Service Research (40/3): 
325–348. Retrieved 9 June 2016 http://www.tandfonline.com/
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Using narrative inquiry with DtC participants
The main finding from DTC research has been that the 
majority of participants are non-completers. Determining 
the reasons for this has been neglected by researchers. 
Broomfield suggests that a lot of information could be 
gleaned from the narratives or stories of non-completers 
regarding why programmes did not work for them and what 
adjustments would enable them to complete. A narrative 
inquiry approach would be the most apt approach to 
examine ‘internal and external dialogues’ that occur when 
deciding to remain or leave. 
Additionally, obtaining descriptions of the offending, lifestyle 
and addiction of non-completers would provide insights 
into how other individuals with similar experiences might be 
helped. It would allow individual stories to be heard. Reasons 
to support this argument are put forward, such as: 
•  Life stories of individuals would include not only the story 
about the addiction and treatment but also insight into 
their experiences of marginalisation and resilience.
•  The transition into drug dependency often co-occurs 
with a life changing event. Broomfield suggests it is 
not just the importance of the event but also whether 
resources are available to manage it.
•  Narratives of those with addiction occur within larger 
narratives of emotive, financial and social systems. 
•  Narratives that unpack the thoughts, needs and risks 
faced by drug users involved with crime would provide 
greater knowledge and understanding to those not 
affected by drug use and crime.
Ciara Guiney
1.    Hickey C (2002) Crime and homelessness. Dublin: Focus 
Ireland, PACE. http://www.drugsandalcohol.ie/5440/ 
2.   Drummond A and Codd M (2014) Drugs and health in 
Irish prisons 2011: a report for prisoners. Dublin: National 
Advisory Committee on Drugs and Alcohol. http://www.
drugsandalcohol.ie/21752/ 
Drug treatment courts continued
Background and methodology
Following previously published findings that substance 
abuse and mental health issues often occur simultaneously, 
especially in adolescents,2 Smyth and colleagues sought 
to examine the prevalence of mental health issues among 
heroin-dependent adolescents and to determine the effect of 
psychologically supported treatment on their mental health. 
In a previous Irish study, it had been noted that heroin-
dependent adolescents experienced more psychological 
distress and a greater number of problems than their peers 
with other substance use disorders.3 
Despite knowing this, the psychological well-being of drug 
users, especially adolescents, remained under-studied. 
Psychological 
health of heroin-
dependent teenagers 
in treatment
A recent Irish study examined the effect of psychologically 
supported opiate substitution treatment (OST) on the 
psychological well-being of an adolescent population 
attending an outpatient clinic in Dublin for their heroin 
dependence.1 It is an important study because of the dearth 
of data reported in the literature on the psychological well-
being of adolescents undergoing OST.
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who did not complete the follow-up BYI and those who did. 
The participants who did not complete the follow-up (n=23) 
were statistically significantly more likely to experience 
homelessness or imprisonment compared to those who did 
complete the follow-up (p=0.02 and p=0.03 respectively). 
Furthermore, the group who did not complete the follow-up 
BYI were more likely to be misusing methadone, heroin and 
cocaine (p<0.001, p=0.001 and p=0.02, respectively). 
Conclusion
The results reported in this study highlight the importance 
of psychosocial support for adolescents undergoing OST. 
They mirror the results found in studies of adults receiving 
OST, where psychological support during treatment was 
found to have a positive impact on psychological well-being.6 
Additionally, this study gives insight into the psychological 
health of teenagers seeking treatment for opiate addiction 
in Dublin and some of the problems experienced by this 
group, which remains poorly characterised. The socio-
demographics of the adolescent cohort in this study is 
reflective of similar adolescent groups internationally, 
especially with regards to poor educational status, family 
difficulties and mental health problems.7,8
Aoife Cannon
1. Smyth BP, Ducray K and Cullen W (2016) Changes in 
psychological well-being among heroin-dependent adolescents 
during psychologically supported opiate substitution treatment. 
Early Intervention in Psychiatry doi:10.1111/epi12318. http://www.
drugsandalcohol.ie/25117/ 
2. Kaminer Y and Bukstein OG (2007) Adolescent substance abuse; 
psychiatric comorbidity and high risk behaviors. New York: 
Haworth Press
3. Keane L, Ducray K and Smyth BP (2014) Psychological 
characteristics of heroin-dependent and non-opiate substance 
dependent adolescents in community drug treatment services 
in Dublin, Ireland. Journal of Child & Adolescent Substance 
Abuse (23): 205–9. http://www.drugsandalcohol.ie/22368/
4. Moore SK, Marsch LA, Badger GJ, Solhkhah R and Hofstein 
Y (2011) Improvement in psychopathology among opioid-
dependent adolescents during behavioural-pharmacological 
treatment. Journal of Addict Medicine (5): 264–71
5. Beck, J.S., Beck, A.T., Jolly, J.B., & Steer, R.A. (2005). Beck Youth 
Inventories Second Edition for Children and Adolescents manual.
6. Gossop M, Marsden J, Stewart D and Treacy S (2001) Outcomes 
after methadone maintenance and methadone reduction 
treatments; two-year follow-up results from the National 
Treatment Outcome Research Study. Drug Alcohol Dependence 
(62): 255–64 
7. Bell J and Mutch C (2006) Treatment retention in adolescent 
patients treated with methadone or buprenorphine for opioid 
dependence; a file review. Drug and Alcohol Review. (25): 167–71
8. Subramaniam GA and Stitzer MA (2009) Clinical characteristics 
of treatment-seeking prescription opioid vs. heroin-using 
adolescents with opioid use disorder. Drug and Alcohol 
Dependence (101): 13–19
The authors of the current paper hypothesised that 
psychological support during OST would result in 
improvements in the psychological health of adolescent 
patients. The study was carried out prospectively on 
individuals aged 18 years or younger who were seeking 
treatment for opiate addiction between May 2006 and 
December 2013 in Dublin. In addition to OST with either 
methadone or buprenorphine, participants in the study were 
also in receipt of individual counselling and group work which 
focused on life skills. Psychological well-being was measured 
at the beginning of the study (baseline) and again after four 
months of treatment (follow-up), using the 2nd edition Beck 
Youth Inventory (BYI-II).4 
The BYI-II is a self-reporting tool with 100 questions based 
on a Likert scale (never, sometimes, often, always), designed 
for use with people aged 18 years or younger. It was created 
to assess the participants’ experience of the following five 
subscales:  
•  self-concept,
•  depression,
•  anxiety,
•  anger, and
•  disruptive behaviour.
For each parameter, scores are converted into a 
standardised score, known as a T-score, which enables  
score comparison between individuals. T-scores were 
compared to age- and gender-matched scores from a 
general population sample. 
While these scores are not diagnostic of psychiatric 
disorders, Smyth and colleagues established ‘normal’ and 
‘abnormal’ cut-off points. For the subscale of self-concept, 
scores of <44 were considered ‘abnormal’, and for the other 
four subscales a score of >55 was considered ‘abnormal’. 
At baseline, structured clinical sessions were carried out 
to assess drug use, and the socio-demographic and clinical 
characteristics of the participants. 
Of the 55 participants that were eligible at the beginning of 
the study, 32 completed treatment and had baseline and 
follow-up (BYI) questionnaires, while 23 participants did not 
complete the follow-up BYI. 
Results
The most novel finding was that all five subscale scores 
improved during the OST period, and the improvements in 
the mean scores for depression, anxiety and anger were 
statistically significant. Interestingly, approximately a third 
of participants with ‘abnormal’ scores for anxiety and 
depression had follow-up scores that were categorised as 
‘normal’. In an attempt to further elucidate the relationship 
between improved scores for depression and heroin use, the 
authors conducted linear regression analysis, which revealed 
greater improvements in depression scores among those 
who were heroin abstinent. 
Psychological health of heroin-
dependent teenagers in 
treatment continued
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Results
Across the five-year period 62 per cent of the urine 
samples tested positive for benzodiazepines, 43 per cent 
for cannabis, 40 per cent for opiates and 11 per cent for 
cocaine. Analysis of substances used at treatment intake, at 
six months and at one- to five-year follow-ups, revealed:
Differences in urinalysis protocols: Extraction of urinalysis 
data from the two national laboratories revealed that 
treatment sites varied considerably regarding the number 
and frequency of urinalysis tests conducted; for example two 
of the seven DAIS treatment clinics requested over 83 per 
cent of analyses, but accounted for only 68 per cent of all 
DAIS clients. The researchers attribute these variations to a 
difference in treatment-site philosophy and practice rather 
than variations in client characteristics.
A further inconsistency occurred between the stated tests 
conducted as part of a routine urine test and what was found 
in the analysis: while 99.9 per cent of urine samples were 
tested for opiates and cocaine as required by policy, only 72 
per cent were tested for benzodiazepines. 
Age of first drug use: Clients who did and did not test 
positive for opiate use at year five were compared on a 
number of variables. No significant difference was found 
apart from age at first drug use (mean age of 15.53 years vs. 
mean of 14.63 years, p=0.008)
 
opiate use: The proportion of clients who tested opiate 
positive fell from 61.8 per cent at initial treatment intake 
to 12.5 per cent at the end of the five-year period. The 
researchers’ time series analysis of weekly proportions 
testing opiate-positive had predicted 16 per cent (95% 
confidence interval: 7%–25%) of clients would be opiate 
positive at the end of the five years. 
other drug use: Significant increases were found in 
benzodiazepine use, and significant increasing effects of 
concurrent cocaine and benzodiazepine use on the likelihood 
of using opiates. It was also possible to link and describe the 
changes in the methadone doses prescribed: analysis of the 
DAIS system revealed there were only minor changes in the 
doses of methadone prescribed over the five years.
Conclusion
With this research the authors have demonstrated that data 
from existing multi-sited, cross-sectional sources can be 
linked, matched, mined and modelled to develop prompt, 
retrospective, sequential outcome results that are useful for 
policy makers, service providers and service users.
Ita Condron
1  Comiskey CM and Snel A (2016) Using clients’ routine urinalysis 
records from multiple treatment systems to model five-year 
opioid substitution treatment outcomes. Substance Use & 
Misuse (51/4): 498–507. http://www.drugsandalcohol.ie/25363/ 
Modelling oSt 
outcomes with 
urinalysis and  
DAIS data
The need for ongoing, prompt, cost-efficient and 
comprehensive monitoring and evaluation of drug treatment 
is well recognised. The scientific literature supports the 
use of randomised controlled trials (RCTs) as the ‘gold 
standard’ research design for evaluating interventions and 
treatment outcomes. However, in community substance-use 
treatment settings, the use of RCTs is not always possible or 
appropriate. There are ethical issues and questions about 
relevance, feasibility and costs. 
Given the limitations of RCTs and the demand for ongoing, 
timely and effective monitoring of treatment outcomes, 
Comiskey and Snel sought to test the feasibility of linking 
laboratory data and client intake data and its usefulness 
for modelling retrospectively five-year longitudinal drug 
treatment outcomes in an Irish opiate treatment setting.1
 
Methodology
A multi-site, retrospective, longitudinal cohort study was 
implemented to evaluate outcomes for opiate users across 
Dublin from January 2006 to December 2010.
Longitudinal urinalyses were extracted from two national 
laboratories which provide substance use screening tests 
to 17 drug treatment sites and to two buses providing 
mobile needle exchange services. During the five-year study 
period a total of 1,734,283 test results were identified for 
330,802 urine samples presented by a total of 4,518 unique 
individuals across Dublin. 
In addition to the urinalysis database, data were extracted 
at a number of ad hoc time points from all the treatment 
sites which use a client electronic record system, which is 
known as the Drugs and AIDS Information System (DAIS). This 
system records data about drug-users seeking treatment, 
including their demographic characteristics, assessment 
prior to treatment, prescriptions, hepatitis C status, 
treatment programmes, needle exchange programmes and 
rehabilitation integration services. During the study period, 
5,430 records relating to 2,832 unique individuals were 
recorded in DAIS; of these unique individuals, 97 per cent 
were Irish, 72 per cent were male, 59.7 per cent had no 
children and seventeen known deaths were recorded. These 
data were linked, via a unique client identity number, at the 
individual client level to the longitudinal urinalysis data.
Once the full database of unique clients was created, with 
each repeat episode of treatment linked, captured and 
recorded for that client, the longitudinal outcome variables 
in the form of drug positive urinalyses results were derived. 
Outcomes were tracked sequentially, with the first urinalyses 
denoted as time point 1 (the intake/baseline measurement) 
and each subsequent urinalysis result was then recorded as 
test 1, 2, 3 … up to a maximum of 260.
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slightly younger than men (30.7 years versus 33.7 years). 
There were no differences in the demographic and social 
characteristics of women and men, except that women were 
more likely to have accessed the support of a social worker. 
Recent drug use was assessed by self-report and urinalysis. 
Men self-reported more use of heroin in the past month and 
had a higher proportion of positive urines for cocaine. 
Women were statistically more likely to report unmet  
needs and achieve lower psychological quality of life scores 
than men. This difference could not be explained by on-
going drug use, as the men in the study had higher levels  
of recent drug use. 
The authors note the limitation of the small sample size. 
In addition, the findings may not be fully representative as 
the study was conducted in a specialist addiction service 
which treats the most complex cases. The generalisability 
of the study is also affected by the fact that the data were 
collected over ten years ago. 
The authors suggest that the needs and quality of life of 
women in MMT warrant further research. They also call on 
addiction services to ensure that the psychological and 
social care needs of women clients are addressed. 
Suzi Lyons
1  Byrne P, Ducray K and Smyth BP (2016) The impact of sex upon 
needs and quality of life within a population on methadone 
treatment Journal of Addiction Medicine 10(1):60–67. http://
www.drugsandalcohol.ie/24979/ 
Women and 
methadone 
maintenance 
treatment 
A study conducted between 2006 and 2007 in the National 
Drug Treatment Centre, a large specialist addiction clinic in 
Dublin, sought to discover whether women in methadone 
maintenance treatment (MMT) had more unmet needs and 
lower quality of life than men in MMT.1 
Any service user who had been receiving MMT for three 
months or more was eligible for inclusion, excluding those 
with a history of acute psychiatric problems or end-
stage health difficulties. In total, 190 service users were 
eligible to participate in the study, of whom 108 (57%) 
agreed to participate. Of those 108 participants, 35 (32%) 
were women. No statistical difference was found in the 
demographic characteristics of those who did and did not 
participate in the study.
Three different standardised questionnaires were used: 
1. WHO Quality of Life – Brief Version (WHO-QOL-Bref),
2. Maudsley Addiction Profile, and 
3.  Camberwell Assessment of Need Short Appraisal 
Schedule, Patient Version. 
The report comprises three sections: 
• a guide for understanding a person’s recovery, identifying 
groups of factors that contribute to successful recovery; 
• a series of measures of each aspect of recovery, drawn 
from published resources which are freely available; and
• guidance on how to implement the shared measurement 
framework, including practicalities such as gathering 
input from service users, training and the use of 
technology in enabling data collection and analysis.
To use the shared measurement framework, services need 
to identify three to five outcomes, match these outcomes 
to the shared outcomes in the framework and identify the 
recommended measurement that accompanies that shared 
outcome. This is the first step in deciding on and using 
common outcomes. The framework recommends established 
questionnaires and psychometric scales to measure 
these outcomes. Services will need training in using these 
questionnaires to gather data and a technical infrastructure 
to facilitate data management and analysis. Understanding 
how shared outcomes data are aggregated and compared will 
help to determine the relative effectiveness of interventions. 
Results must be presented in a way that allows services to 
learn about what is and is not working in recovery services and 
to make the necessary changes and improvements. 
Shared measurement 
of personal outcomes 
in recovery
In April 2016 a number of drugs and alcohol taskforce 
coordinators and other staff along with representatives 
of various drugs projects participated in a workshop on 
shared measurement of personal outcomes in recovery. 
The purpose of the workshop was to help services identify 
common outcomes and work towards a shared system of 
measurement for interventions in rehabilitation and social 
reintegration. 
The workshop was hosted by the HRB National Drugs Library, 
which seeks to encourage the use of research-based 
evidence in decision-making and to contribute to learning in 
drugs and alcohol taskforces and addiction services. 
The workshop facilitators have compiled a report based on 
the discussions at the workshop, the findings from a survey 
of taskforces and interviews with a number of taskforce 
coordinators. 
27
Issue 58 | Sum
m
er 20
16
      drugnet IR
ELAN
D
      
needs change over the course of the recovery process and 
how needs differ from person to person. 
There is an evidence gap in this area and a lack of consistency 
when it comes to evaluating recovery interventions. Shared 
measurement of the impact services have on recovering drug 
users would help to lessen this gap, improve services and 
make achievements in this work more apparent. It would lead 
to better outcomes for the people using services and provide 
evidence that taskforces play an integral and valuable part 
in responding to problem drug use in Ireland. Deciding on 
appropriate personal outcomes in recovery, which services 
can recognise as milestones in the achievement of their goals, 
and agreeing on indicators to measure these outcomes are 
important first steps in building knowledge, sharing it and using 
it to spread good practice.
Over the coming weeks a number of taskforces will work 
on the next phase in the development of the outcomes 
framework and seek to ensure that it is relevant and 
meaningful to services users, making it more likely to 
be implemented and used effectively. Service user 
consultation will encourage a sense of ownership of the 
measurement system, ensure the measurements used are 
proportionate and the service user experience is clearly 
and accurately articulated.
Brian Galvin
1  Munton T, Wedlock E and Gomersall A (2014) The role of 
social and human capital in recovery from drug and alcohol 
addiction. HRB Drug and Alcohol Evidence Review 1. Dublin: 
Health Research Board. http://www.drugsandalcohol.ie/23078/ 
Responding to the needs of those recovering from addiction 
is multi-faceted and demanding work, requiring knowledge, 
personal skills and determination. Good service is built by 
selecting interventions which are known to be effective, 
monitoring the implementation of these services and 
responding to information gained through rigorous evaluation 
and sharing of knowledge. In this way good practice is 
identified and spread, resources are used effectively and 
services developed in a shared learning environment. 
Housing, education and employment have been identified 
as key elements in reintegrating those overcoming addiction 
into their communities. Recovering drug users need social 
and emotional support beyond the initial treatment period 
to develop their capacity to participate in the housing, 
education and employment spheres. Recovery is multi-
faceted but this project is particularly concerned with the 
measurement of personal outcomes in this process, the 
types of change in outlook and self-perception that enable 
progress along the recovery path. 
The HRB’s evidence review on social capital in recovery1 looked 
at the role played by friends and families in helping the service 
user to develop a secure social network, to find examples 
of success and to develop the confidence to plan their own 
lives. The review found good evidence that social and human 
capital contribute to recovery. It identified a number of areas 
for future work so that service providers can understand how 
Personal outcomes in recovery 
continued
Community mobilisation
Underpinning the pilot project’s approach was the finding 
of the National Substance Misuse Strategy that community 
mobilisation is successful in bringing stakeholders together 
to develop alcohol and drug policies. The author of the 
evaluation report describes community mobilisation as a 
public health approach to reducing alcohol-related harm: it 
changes the context in which alcohol use occurs, rather than 
focusing on the ‘problem drinker’. It is a process through 
which communities work together to take action and bring 
about change, working with a range of stakeholders from the 
public, statutory and private sectors to identify the changes 
they want to bring about in their area. Based on the best 
evidence available the different stakeholders plan together 
how to bring about the desired changes. The community 
then implements the plan and monitors its progress in 
reducing alcohol-related harm. Some common features of 
the approach are shown in Figure 1 on the next page.
The evaluation report contains a review of the literature on 
community mobilisation and shows how elsewhere it has 
been effective in reducing alcohol-related harm. The author 
identifies key elements that contribute to positive results 
when working in this way, including: 
• establishing well-functioning coalitions, 
• getting wider community buy-in to the process and its 
aims, 
• changing the policy context, 
Community 
mobilisation and local 
alcohol action plans: 
an evaluation 
A report on the National Community Action on Alcohol Pilot 
Project (NCAAPP) was published in December 2015.1 The 
findings of this report, a process evaluation of the project 
which began in 2015, are outlined below.
Background
On foot of the National Substance Misuse Strategy,2 the remit 
of the drugs task forces was expanded in 2014 to include 
alcohol. To support the task forces in meeting the demands 
of this new remit, the NCAAPP was established. Its aim was to 
support task forces in developing a ‘community mobilisation 
approach’ which would inform the development of policies 
to address alcohol use, and reduce alcohol-related harm, in 
their area. The project was delivered by the Alcohol Forum 
in partnership with the Drug Programmes and Policy Unit of 
the Department of Health and the Wellbeing Division of the 
Health Service Executive. 
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The training and support delivered was of a high quality and 
was delivered by a highly dedicated trainer. Participants 
improved their knowledge of alcohol-related harms and 
the networking opportunities afforded by the centralised 
training sessions were seen as beneficial. The training also 
led to changes in work practices, for example a public health 
approach to alcohol issues was adopted, evidence-based 
measures were applied, and a community mobilisation model 
was used. 
At the core of the project was the production of local 
alcohol action plans. Four of the five task forces completed 
local alcohol action plans by the end of the project and the 
fifth had an outline plan. All the completed action plans 
included monitoring, review and self-evaluation measures. 
A number of critical barriers were identified. Building 
local leadership and commitment to the project proved 
challenging, as did engaging stakeholders to lead a collective 
approach. Limited resources presented hurdles when it 
came to making and implementing a plan. Finally, local policy 
changes to help lower alcohol-related harm needed to be 
reinforced by a government-level commitment to adopting 
such evidence-based policies. 
The author makes a range of recommendations at the end of 
the report. She highlights the fact that community action on 
alcohol is a long-term process and that the pilot project was 
just the beginning of the process for those involved.
Lucy Dillon
1  Galligan C (2016) National community action on alcohol pilot 
project 2015: external evaluation project. Dublin: Department 
of Health. http://www.drugsandalcohol.ie/25098/
2  Department of Health (2012) Steering group report on a 
national substance misuse strategy. Dublin: Department of 
Health. http://www.drugsandalcohol.ie/16908/ 
• taking an evidence-based approach, 
• giving the project adequate time to get established and 
deliver on outcomes (in excess of three years),
• taking a multi-strategy approach, and
• using the media to support interventions. 
Evaluation findings 
Drawing any conclusions about the effectiveness of the 
NCAAPP in reducing alcohol-related harm was beyond 
the scope of this evaluation. Instead, the report explored 
the effectiveness of the process put in place to deliver 
on community mobilisation and to establish local alcohol 
action plans. 
Five task forces were selected to take part in the project, 
each of which identified a project lead and established an 
‘alcohol sub-committee’ with responsibility for delivering 
on the project in their area. Each sub-committee sent a 
representative on five one-day formal training sessions in 
Dublin. These covered a range of topics including community 
mobilisation, data collection, research and evaluation 
methods, logic models, alcohol-related harm, using the 
media, and effective policy measures to address alcohol 
harms. The task forces then received on-site tailored 
support to help develop their local plans, as well as access 
to follow-up support via phone calls, emails, one-on-one 
meetings and some on-site group training. One individual 
from the Alcohol Forum had responsibility for delivering this 
programme of training and support. 
Broadly speaking, the goals of the project were to train 
stakeholders on drug-related harm, raise awareness of policy 
measures, support community engagement, and develop 
local action plans. The evaluation found that, overall, the 
project was successful in these areas. 
Figure 1: Common stages in a community mobilisation process (Galligan 2016: p24)
Community mobilisation and 
local alcohol action plans continued
Formulation 
of a community
coalition, 
involving key 
stakeholders
Implementing plan
(including policy
change) and 
evaluting progress
Training in areas
of alcohol related
harm and evidence 
based measures
Identifying
approach to address
harms identiﬁed
(includes a media 
strategy)
Local research to
inform actions
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given a care plan; 43 per cent never felt they had a 
meaningful discussion with a doctor, and 34 per cent did 
not know this was an option.
• Lack of choices – 94 per cent said they had never been 
offered an alternative to MMT.
Following a dialogue process regarding these findings, the 
researchers identified three emerging themes:
• Powerlessness within the whole system – who has the 
power to make change, and who is accountable?
• voice and participation of the service user is valued  
– but who is listening?
• Stuck conversation – harm reduction versus abstinence.
Brigid Pike
1  O’Connell N (2015, 12 November) Developing a human rights 
approach to delivery of drug services. PowerPoint presentation 
delivered at CityWide 20th Anniversary conference. Retrieved 
27 April 2016 at http://www.citywide.ie/publications/listing/
developing-a-human-rights-approach-to-delivery-of-drug-
services
SERVICES
Service users’ rights
According to a presentation by Niall O’Connell of Service User 
Rights in Action Group and Community Action Network (CAN) 
at CityWide’s 20th Anniversary conference in November 2015,1 
users of MMT services encounter three practices which may be 
classed as human rights abuses. The practices were identified 
in the course of research conducted with clients of methadone 
maintenance treatment (MMT) services in 2013, which included 
a questionnaire completed by 101 respondents. 
The three practices are:
• Urine sampling – procedures for obtaining samples 
were based on the assumption that people will cheat, 
and there was a lack of consistency in the frequency of 
sampling and conduct of the tests.
• Lack of meaningful review – 83 per cent of respondents 
were not asked their opinion; 62 per cent were never 
The app is free and can be downloaded for Android or  
Apple from the usual sources, using the search terms  
‘sand drugs’ or simply scan the QR code. It can then be  
used on- or off-line.
Android   Apple
To get more information see: http://www.ndublinrdtf.ie/
sand-drug-alcohol-information-app/
Suzi Lyons
New app for  
drug information 
North Dublin Regional Drugs and Alcohol Task Force 
(NDRDATF) has developed SAND (Substance Abuse North 
Dublin), an app that provides clear, factual and accessible 
information on alcohol and drugs.
The app was launched on 27 April 2016 by Dr Gerry 
McCarney from SASSY (Substance Abuse Service Specific to 
Youth), along with Louise McCulloch, care coordinator for 
NDRDATF, who project managed the project, and Bríd Walsh, 
coordinator of NDRDATF. 
Louise McCulloch described how the task force had been 
looking for a way to provide information on alcohol and drugs 
to as many people as possible in their region, a large and 
varied geographic area. The task force felt that using social 
media would help them engage better with young people. 
Development of the app was a collaborative process, 
involving the community and with local Leaving Cert students 
testing the app and providing invaluable feedback.
The app has four sections:
1. Information on alcohol and drugs 
2.  A quiz to test your knowledge about drugs  
– six questions only, but they change randomly
3. Signs to look out for
4. How to get help
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Recent 
publications
The following abstracts are cited from 
recently published journal articles relating 
to the drug situation in Ireland 
the association between scholastic 
measures, alcohol outcome 
expectancies and alcohol use: a cross-
sectional study in Northern Ireland
McKay MT and Harvey SA (2015) Child Care 
in Practice 21 (4): 357–373 
http://www.drugsandalcohol.ie/25319/
Alcohol use among adolescents is 
associated with both short-term (truancy, 
illness, trouble with police) and long-term 
(dependence, unemployment) negative 
consequences. Moreover, because of 
its developmental nature, adolescent 
drinking behaviour is difficult to accurately 
assess. Individual-level scholastic variables 
and alcohol outcome expectancies 
have been found to be associated with 
drinking behaviours. This study used a 
cross-sectional design to investigate: 
the relationship between alcohol use 
and individual-level scholastic variables, 
namely academic motivation and academic 
self-efficacy; and the relationship 
between alcohol use and alcohol outcome 
expectancies, while controlling for a wide 
range of other variables. 
Participants were post-primary (high) 
school pupils in the greater Belfast area 
of Northern Ireland. They completed a 
range of questionnaires including measures 
assessing academic self-efficacy, academic 
motivation, alcohol outcome expectancies, 
and a composite measure of alcohol use. 
Results showed that, controlling for the 
hierarchical nature of the data, socio-
demographic variables and other possible 
confounders, lower reported scores on 
the individual-level scholastic measures, 
higher reported scores on positive alcohol 
outcome expectancies, and lower reported 
scores on negative alcohol outcome 
expectancies remained significantly 
associated with more problematic drinking. 
Results are discussed in the context of 
contemporaneous school-related research. 
opt-out panel testing for HIv, 
hepatitis B and hepatitis C in an urban 
emergency department: a pilot study
O’Connell S et al PLoS ONE 11 (3)  
http://www.drugsandalcohol.ie/25298 
Studies suggest 2 per 1000 people in Dublin 
are living with HIV, the level above which 
universal screening is advised. We aimed 
to assess the feasibility and acceptability 
of a universal opt-out HIV, Hepatitis B 
and Hepatitis C testing programme for 
Emergency Department patients and to 
describe the incidence and prevalence of 
blood-borne viruses in this population.
An opt-out ED blood borne virus screening 
programme was piloted from March 2014 
to January 2015. Patients undergoing 
blood sampling during routine clinical 
care were offered HIV 1&2 antibody/
antigen assay, HBV surface antigen and 
HCV antibody tests. Linkage to care where 
necessary was co-ordinated by the study 
team. New diagnosis and prevalence rates 
were defined as the new cases per 1000 
tested and number of positive tests per 
1000 tested respectively.
Over 45 weeks of testing, of 10,000 
patient visits, 8,839 individual patient 
samples were available for analysis 
following removal of duplicates. A 
sustained target uptake of >50% was 
obtained after week 3. 97(1.09%), 
44(0.49%) and 447(5.05%) HIV, Hepatitis 
B and Hepatitis C tests were positive 
respectively. Of these, 7(0.08%), 
20(0.22%) and 58(0.66%) were new 
diagnoses of HIV, Hepatitis B and Hepatitis 
C respectively. The new diagnosis rate 
for HIV, Hepatitis B and Hepatitis C was 
0.8, 2.26 and 6.5 per 1000 and study 
prevalence for HIV, Hepatitis B and 
Hepatitis C was 11.0, 5.0 and 50.5 per  
1000 respectively.
Opt-out blood borne viral screening was 
feasible and acceptable in an inner-city 
ED. Blood borne viral infections were 
prevalent in this population and newly 
diagnosed cases were diagnosed and 
linked to care. These results suggest 
widespread blood borne viral testing in 
differing clinical locations with differing 
population demographic risks may be 
warranted. 
Chillin, buzzin, getting mangled, and 
coming down: Doing differentiated 
normalisation in risk environments
O’Gorman A (2016) Drugs: Education 
Prevention and Policy 23 (3): 247–254 
http://www.drugsandalcohol.ie/25573/
This paper examines differentiated 
normalisation through the lens of young 
drug users from a marginalised Dublin 
neighbourhood where drugs are readily 
available, prevalence rates are high, and 
a flourishing drugs market operates. The 
narratives of these marginalised young 
people illustrate how drug use and 
drug choices are shaped by different 
intentions, avowed identities and 
diverse structural, temporal and socio-
spatial settings. Their routines and drug 
repertoires echo the (mainly) reasoned 
consumption choices, the cost–benefit 
analyses and the emphasis on pleasure 
and fun ascribed to recreational drug 
users, including those who underpin the 
normalisation concept. However, their 
drug using practices continue to be 
rendered deviant due to their experience 
of social exclusion; exclusion from 
consumption-orientated lifestyles and 
from the night time economy; and their 
inclusion in the informal drugs economy. 
Normalisation is relative (not just 
differentiated) to the social status of the 
drug user. A reconstructed normalisation 
thesis inclusive of class (and race, and 
gender) could explore why the use of 
similar drugs and similar drug using 
behaviours by different social groups 
is differentially accommodated and 
accepted by mainstream society.
off the record: substance-related 
disorders in the undergraduate 
medical curricula in Ireland 
Willson M, Cullen W and Klimas (2016) 
Journal of Substance Use Early online  
http://www.drugsandalcohol.ie/25572/ 
Substance use disorders (SUDs) are a 
worldwide problem, and have become 
a major health concern in Ireland 
particularly. We aimed to determine 
the extent to which addiction medicine 
is embedded in the undergraduate 
medical curriculum in Ireland. To further 
investigate the degree to which drug 
addiction is taught in the Irish medical 
curriculum an online literature search 
was performed using Google Scholar, 
PubMed (from 2009 to present), EMBASE, 
PsycINFO, CINAHL, and Medline using the 
keywords “substance-related disorders,” 
“undergraduate,” “curriculum” and 
“Ireland.” Additionally, all Irish medical 
school websites were examined (n = 6), 
and a Google search and manual searches 
of conference programs were performed. 
We used the Preferred Reporting Items 
for Systematic Review and Meta-Analysis 
(PRISMA) guidelines to systematically 
review and discuss findings.
A total of zero published studies met 
the criteria for inclusion in an updated 
systematic literature search of addiction 
medicine education in the undergraduate 
medical curriculum in Ireland. There is 
currently no documentation of drug 
addiction teaching sessions in Irish 
medical schools. Investigations that offer 
direct contact with medical schools, such 
as a telephone survey, may provide a more 
accurate representation of how addiction 
medicine education is incorporated into 
the medical school curricula.
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Use of hierarchical cluster analysis 
to classify prisons in Ireland into 
mutually exclusive drug-use risk 
categories
Codd M et al. (2016) Drugs: Education 
Prevention and Policy 23 (2): 93–98 
http://www.drugsandalcohol.ie/25537/ 
The aim of this paper is to propose a 
methodology for classifying prisons into 
distinct drug-use risk categories based on 
prisoners’ use of specified prescription 
and illegal drugs. The categories of prisons 
thus defined have particular relevance for 
the planning of drug-related interventions, 
education and services in Irish prisons. 
The methodology may be transferable to, 
and of value in, prison systems elsewhere.
From the 14 prisons in Ireland, 824 
randomly selected prisoners completed 
a self-administered questionnaire on 
lifetime, last year and last month use 
of specified prescription and non-
prescription drugs. Questions were 
derived from the European Monitoring 
Centre for Drugs and Drug Addiction 
(EMCDDA) and other sources. Oral fluid 
samples were collected for verification of 
recent drug use. The EMCDDA definition 
of “recent problematic drug use” was 
used in post hoc hierarchical cluster 
analysis to define categories of prisons 
with similar drug-use patterns. Four 
categories of prisons, designated “low”, 
“medium”, “high” and “very high” drug 
use, were identified. While the prisons 
comprising each category were known, 
drug use patterns in individual prisons 
were not disclosed because of concerns 
about prisoner confidentiality in a small 
jurisdiction. The clusters identified were 
used to contextualise subsequent analyses 
of drug use, the availability and use of 
harm-reduction services and differential 
service requirements by prison category.
The methodology described allows for 
identification of prison categories by 
drug-use patterns. With restrictions on 
disclosure of information by individual 
prison, it provides more valuable 
information than would derive from data 
on all prisons combined. 
Using clients’ routine urinalysis 
records from multiple treatment 
systems to model five-year opioid 
substitution treatment outcomes 
Comiskey C M and Snel A (2016) Substance 
Use & Misuse 51 (4): 498–507  
http://www.drugsandalcohol.ie/25363/ 
At global, national, and local level, 
the need for ongoing, timely and cost 
efficient, comprehensive drug treatment 
monitoring, and evaluation systems have 
clearly been well recognized.
To test the feasibility of linking laboratory 
data and client intake data and its 
usefulness for modeling retrospectively, 
for the first time, 5-year longitudinal drug 
treatment outcomes in an Irish opiate 
treatment setting.
A multisite, retrospective, longitudinal 
cohort study was implemented to evaluate 
outcomes for opiate users based on 1.7 
million routine urinalysis results collected 
from 4,518 individuals presenting for 
opioid substitution treatment in Ireland 
from January 2006 to December 2010.
Analysis of opiates, cocaine, 
benzodiazepine, and cannabis use 
at treatment intake, 6 months and 
at 1-5 year follow-ups revealed 
differences in urinalysis protocols; 
significant differences in age of first 
drug use between those using and not 
using opiates at 5 years; significant 
decreases in opiate use; increases in 
benzodiazepine use and significant 
increasing effects of concurrent cocaine 
and benzodiazepine use on the odds 
of using opiates. Time series analysis 
of weekly proportions opiate positive 
predicted 16% (95% confidence interval: 
7%-25%) of clients would be opiate 
positive 5 years postinitial intake. 
Conclusions/Importance: Underutilized 
urinalysis data can be used to address the 
need for cost effective, efficient evidence 
of drug-treatment outcomes across time, 
place, and systems. Linking and matching 
the cross-sectional data across sites and 
times also revealed where improvements 
in electronic records could be made. 
Ireland’s financial crisis and its 
influence on alcohol and drug issues
Butler S and Hope A (2015) Nordic Studies 
on Alcohol and Drugs 32 (6): 623–628 
http://www.drugsandalcohol.ie/25123/ 
Budget 2009 (announced in December 
2008) increased tax on alcohol, resulting 
in a drop in consumption; Budget 
2010 decreased tax and consumption 
increased; Budget 2013 increased tax and, 
again, consumption decreased. Prior to 
the crash of 2008, a shift in the pattern 
of alcohol purchasing, from pub or ‘on-
premise’ to supermarket or ‘offlicence’ 
purchasing had already emerged; this 
was a shift which had been facilitated 
by the introduction in the year 2000 of 
more liberal licensing regulations (Hope, 
2014). What this meant in practice was 
that the number of pubs declined while, 
between 2002 and 2009, the number 
of off-licence retail outlets doubled 
(Revenue Commissioners Annual Reports). 
One key influence on the expansion of 
the off-licence sector was the abolition in 
2006 of the Groceries Order. This meant 
that, for the first time, Irish retailers could 
now sell alcohol at below-cost price; and 
supermarkets in particular, were quick to 
seize the advantage of using very cheap 
alcohol as a loss leader which would 
increase ‘footfall’, thereby increasing their 
customer bases 
Alcohol consumption among 
university students in Ireland and 
the United Kingdom from 2002 to 
2014: a systematic review
Davoren MP, Demant J, Shiely F  
and Perry I J (2016) BMC Public  
Health 16 (1): 173  
http://www.drugsandalcohol.ie/25221/ 
Alcohol is a leading cause of global 
suffering. Europe reports the uppermost 
volume of alcohol consumption in the 
world, with Ireland and the United 
Kingdom reporting the highest levels of 
binge drinking and drunkenness. Levels 
of consumption are elevated among 
university students. Thus, this literature 
review aims to summarise the current 
research on alcohol consumption among 
university students in the Republic of 
Ireland and the United Kingdom.
MEDLINE, CINAHL, EMBASE and PsychInfo 
were systematically searched for literature 
from January 2002 until December 2014. 
Each database was searched using the 
following search pillars: alcohol, university 
student, Ireland or the United Kingdom 
and prevalence studies.
Two thousand one hundred twenty eight 
articles were retrieved from electronic 
database searching. These were title 
searched for relevance. 113 full texts were 
retrieved and assessed for eligibility. 
Of these, 29 articles were deemed to 
meet inclusion criteria for the review. 
Almost two thirds of students reported 
a hazardous alcohol consumption score 
on the AUDIT scale. Over 20 % reported 
alcohol problems over their lifetime using 
CAGE while over 20 % exceed sensible 
limits each week. Noteworthy is the 
narrowing of the gender gap throughout 
the past decade.
This is the first review to investigate 
consumption patterns of university 
students in Ireland and the United 
Kingdom. A range of sampling strategies 
and screening tools are employed 
in alcohol research which preclude 
comparability. The current review provides 
an overview of consumption patterns to 
guide policy development. 
Modeling problem behaviors in a 
nationally representative sample of 
adolescents
O’Connor K L et al. (2016) Journal of 
Adolescence 50: 6–15 
http://www.drugsandalcohol.ie/25524/ 
Research on multiple problem behaviors 
has focused on the concept of Problem 
Behavior Syndrome (PBS). Problem 
Behavior Theory (PBT) is a complex and 
recent publications continued
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framework designed to explain the 
development of a range of problem 
behaviors. This study examines the 
structure of PBS and the applicability 
of PBT in adolescents. Participants 
were 6062 adolescents; aged 12-19 
(51.3% female) who took part in the My 
World Survey-Second Level (MWS-SL). 
Regarding PBS, Confirmatory Factor 
Analysis established that problem 
behaviors, such as alcohol and drug use 
loaded significantly onto a single, latent 
construct for males and females. Using 
Structural Equation Modeling, the PBT 
framework was found to be a good fit for 
males and females. Socio-demographic, 
perceived environment system and 
personality accounted for over 40% of 
the variance in problem behaviors for 
males and females. Our findings have 
important implications for understanding 
how differences in engaging in problem 
behaviors vary by gender. 
Screening and brief interventions 
for illicit drug use and alcohol use 
in methadone maintained opiate-
dependent patients: results of a 
pilot cluster randomized controlled 
trial feasibility study
Darker CD et al. (2016) Substance Use & 
Misuse Early online : 1–12  
http://www.drugsandalcohol.ie/25507/ 
The present study evaluated the 
effectiveness of a single clinician 
delivered brief intervention (BI) to reduce 
problem alcohol use and illicit substance 
use in an opiate-dependent methadone 
maintained cohort of patients attending 
for treatment.Four addiction treatment 
centers were randomly assigned to either 
treatment as usual (TAU; control group) 
or BI (intervention group). Clinicians 
screened patients using the alcohol, 
smoking, and substance involvement 
screening test (ASSIST) screening tool at 
baseline and again at three-month follow 
up. Fidelity checks were performed 
to ensure that training was delivered 
effectively and uniformly across all 
study sites. Feasibility of administering 
a BI within daily practice was assessed 
through intervention fidelity checks, 
patient satisfaction questionnaires and 
process evaluation
A total of 465 patients were screened 
(66% of the overall eligible population) 
with a total of 433 (93%) ASSIST positive 
cases. Randomization was effective, 
with no differences in the control versus 
the intervention arms at baseline for 
key demographic or clinical indicators 
including substance us. There was a 
statistically significant difference between 
global risk score for the intervention (x = 
39.36, sd = 25.91) group and the control 
group (x = 45.27, SD = 27.52) at 3-month 
follow-up (t(341) = -2.07, p < .05). This 
trial provides the first evidence that a 
single clinician delivered BI can result 
in a reduction in substance use within a 
methadone maintained opiate-dependent 
cohort, and this effect is sustained at 
three month follow up. 
Safe storage of methadone in 
the home. An Irish audit of the 
effectiveness of information 
provision in pharmacies
Horan JA , Gooney M and Van Hout MC 
(2016) Heroin Addiction and Related 
Clinical Problems 18 (2): 31–40  
http://www.drugsandalcohol.ie/25212/ 
Safe storage of oral methadone at home 
is an important issue given the risk of 
accidental paediatric consumption. 
Pharmacy protocols centre on provision of 
information to patients relating to general 
and paediatric dangers of methadone and 
safe storage of methadone in the home.
The study aimed to audit the effectiveness 
of pharmacy provision of information on 
safety of methadone consumption and 
storage in the home.
The study involved an audit of five 
criteria relating to patient awareness of 
general dangers of methadone use and 
paediatric risks, patient information recall 
on safe storage of methadone in the 
home; take home methadone dispensing 
in child resistant containers and safe 
and secured storage of methadone. 
Audit information was collected using a 
survey with consecutive adult patients 
attending a specialist methadone clinic 
over the course of four weeks (n=94), 
and telephone interviews with dispensing 
pharmacists recorded in the specialist 
clinic register (n=43).
None of the criteria reached a 100% 
standard. 51% reported never being 
provided with safety information. 97% 
of patients were aware of the dangers of 
methadone use, with females significantly 
more aware of dangers of methadone 
to users. 86% did not place their take-
home methadone in a locked place. 90% 
reported they would seek medical help 
if a child had accidentally consumed 
methadone. 58% of pharmacists never 
questioned patients around storage, but 
58% reported counselling patients on 
safe storage. 
A typology of alcohol consumption 
among young people – A narrative 
synthesis
Davoren MP et al. (2015) Addiction 
Research & Theory Early online  
http://www.drugsandalcohol.ie/25207/ 
Currently, alcohol consumption levels are 
significantly higher among younger age 
groups. However, previous research has 
noted the diversity of motivations and 
patterns. These patterns of drinking have 
yet to be synthesised into a typology. The 
aim of the current study was to synthesise 
information from studies that produced 
types of alcohol consumption among 
young people.
Quantitative and qualitative literature 
investigating the different types of 
drinkers among young people [aged 
12–24 years], published in peer reviewed 
journals, were eligible for inclusion in this 
systematic review. MEDLINE, PsychInfo 
and CINAHL were systematically 
searched for relevant articles published 
between January 1st 2000 and 
December 31st 2014. Included papers 
were critically appraised. A narrative 
synthesis approach was employed based 
on guidance from the UK Economic and 
Social Research Council.
In total, 13 studies were eligible for 
inclusion: 11 quantitative, one qualitative 
and one mixed methods. Six classes 
of drinkers were formed within this 
typology. Abstainers reported no alcohol 
consumption. Light drinkers reported 
drinking small amounts of alcohol 
infrequently. In comparison, social and 
hedonistic drinkers drank most in social 
situations and to have fun. Heavy and 
harmful consumers reported increased 
volume and frequency of consumption 
including harmful consequences.
Currently, policy makers are attempting to 
combat the high levels of harmful alcohol 
consumption among young people. The 
current typology provides guidance for 
targeted interventions in addition to a 
practical analytic tool in future research.
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